Motif ID: Snai1_Zeb1_Snai2
Z-value: 1.973
Transcription factors associated with Snai1_Zeb1_Snai2:
| Gene Symbol | Entrez ID | Gene Name |
|---|---|---|
| Snai1 | ENSMUSG00000042821.7 | Snai1 |
| Snai2 | ENSMUSG00000022676.6 | Snai2 |
| Zeb1 | ENSMUSG00000024238.7 | Zeb1 |
Activity-expression correlation:
| Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| Zeb1 | mm10_v2_chr18_+_5591860_5591902 | -0.78 | 1.1e-16 | Click! |
| Snai2 | mm10_v2_chr16_+_14705832_14705858 | -0.21 | 6.2e-02 | Click! |
| Snai1 | mm10_v2_chr2_+_167538192_167538210 | -0.01 | 9.1e-01 | Click! |
Top targets:
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 9.7 | 29.1 | GO:0042323 | negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
| 7.5 | 22.5 | GO:0099548 | trans-synaptic signaling by nitric oxide(GO:0099548) |
| 6.7 | 20.2 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
| 5.8 | 34.6 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
| 5.0 | 15.1 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
| 5.0 | 19.9 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 4.4 | 13.3 | GO:0021577 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
| 4.4 | 13.1 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 4.4 | 13.1 | GO:0010752 | regulation of cGMP-mediated signaling(GO:0010752) |
| 4.3 | 21.5 | GO:0075136 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
| 4.1 | 16.5 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
| 4.1 | 12.4 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 4.0 | 16.1 | GO:1990379 | lipid transport across blood brain barrier(GO:1990379) |
| 4.0 | 27.8 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 4.0 | 23.7 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 3.9 | 19.7 | GO:1903609 | negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
| 3.9 | 11.7 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
| 3.8 | 11.3 | GO:1903538 | meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
| 3.7 | 26.1 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 3.5 | 10.6 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
| 3.4 | 13.6 | GO:0048686 | regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
| 3.3 | 13.4 | GO:0021564 | glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
| 3.2 | 9.7 | GO:2000501 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
| 3.2 | 12.8 | GO:0021586 | pons maturation(GO:0021586) |
| 3.1 | 6.2 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
| 3.0 | 17.9 | GO:0032796 | uropod organization(GO:0032796) |
| 2.9 | 2.9 | GO:0070428 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070432) |
| 2.9 | 20.5 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 2.9 | 8.7 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
| 2.8 | 17.1 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 2.8 | 11.4 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
| 2.8 | 11.4 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
| 2.8 | 5.6 | GO:0098917 | retrograde trans-synaptic signaling(GO:0098917) |
| 2.8 | 8.3 | GO:0030827 | negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
| 2.7 | 13.6 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 2.7 | 10.8 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 2.7 | 8.1 | GO:0051715 | cytolysis in other organism(GO:0051715) |
| 2.7 | 2.7 | GO:1904809 | dense core granule localization(GO:0032253) dense core granule transport(GO:1901950) regulation of dense core granule transport(GO:1904809) positive regulation of dense core granule transport(GO:1904811) |
| 2.7 | 10.6 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
| 2.6 | 15.5 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
| 2.6 | 2.6 | GO:0032808 | lacrimal gland development(GO:0032808) |
| 2.5 | 7.6 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
| 2.4 | 7.3 | GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
| 2.4 | 7.3 | GO:0098886 | modification of dendritic spine(GO:0098886) |
| 2.4 | 16.9 | GO:0070494 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
| 2.4 | 7.2 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
| 2.4 | 21.3 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
| 2.3 | 7.0 | GO:0002159 | desmosome assembly(GO:0002159) |
| 2.3 | 6.9 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 2.3 | 11.3 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 2.3 | 11.3 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 2.2 | 6.6 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
| 2.1 | 12.7 | GO:0097646 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 2.1 | 18.9 | GO:0071420 | cellular response to histamine(GO:0071420) |
| 2.1 | 10.5 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
| 2.1 | 6.3 | GO:0002182 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
| 2.1 | 8.3 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) |
| 2.1 | 6.2 | GO:0060596 | mammary placode formation(GO:0060596) |
| 2.0 | 10.2 | GO:1902287 | trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
| 2.0 | 14.3 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
| 2.0 | 10.1 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
| 2.0 | 6.0 | GO:0042823 | pyridoxal phosphate biosynthetic process(GO:0042823) |
| 2.0 | 2.0 | GO:1901608 | regulation of vesicle transport along microtubule(GO:1901608) |
| 2.0 | 23.9 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 2.0 | 5.9 | GO:2000170 | positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
| 1.9 | 3.8 | GO:0002586 | regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002580) positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 1.9 | 3.8 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
| 1.9 | 5.6 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
| 1.8 | 5.5 | GO:0043181 | vacuolar sequestering(GO:0043181) |
| 1.8 | 7.3 | GO:1904457 | positive regulation of neuronal action potential(GO:1904457) |
| 1.8 | 7.3 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
| 1.8 | 1.8 | GO:0032902 | nerve growth factor production(GO:0032902) |
| 1.8 | 5.4 | GO:0042196 | dichloromethane metabolic process(GO:0018900) chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
| 1.8 | 7.1 | GO:0016128 | phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
| 1.8 | 5.3 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
| 1.8 | 3.5 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
| 1.8 | 17.6 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
| 1.8 | 1.8 | GO:1903011 | negative regulation of bone development(GO:1903011) |
| 1.7 | 5.2 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
| 1.7 | 3.5 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
| 1.7 | 10.3 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
| 1.7 | 5.1 | GO:0032765 | positive regulation of mast cell cytokine production(GO:0032765) |
| 1.7 | 3.4 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
| 1.7 | 3.4 | GO:0050909 | sensory perception of taste(GO:0050909) |
| 1.7 | 8.3 | GO:0042701 | progesterone secretion(GO:0042701) |
| 1.7 | 11.6 | GO:0019532 | oxalate transport(GO:0019532) |
| 1.7 | 5.0 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) positive regulation of aminoacyl-tRNA ligase activity(GO:1903632) |
| 1.7 | 8.3 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
| 1.6 | 4.9 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
| 1.6 | 3.3 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
| 1.6 | 6.5 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 1.6 | 14.6 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
| 1.6 | 4.8 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
| 1.6 | 12.9 | GO:0098967 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 1.6 | 7.9 | GO:0032423 | regulation of mismatch repair(GO:0032423) |
| 1.6 | 22.1 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
| 1.6 | 6.3 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
| 1.6 | 7.8 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 1.6 | 3.1 | GO:0045687 | positive regulation of glial cell differentiation(GO:0045687) |
| 1.5 | 1.5 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
| 1.5 | 4.6 | GO:0050925 | negative regulation of negative chemotaxis(GO:0050925) |
| 1.5 | 4.5 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
| 1.5 | 9.0 | GO:1903207 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
| 1.5 | 4.5 | GO:1990523 | bone regeneration(GO:1990523) |
| 1.5 | 8.9 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 1.5 | 8.8 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
| 1.5 | 17.6 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
| 1.5 | 11.6 | GO:0051014 | actin filament severing(GO:0051014) |
| 1.4 | 2.9 | GO:0097107 | postsynaptic density organization(GO:0097106) postsynaptic density assembly(GO:0097107) guanylate kinase-associated protein clustering(GO:0097117) |
| 1.4 | 11.5 | GO:0005513 | detection of calcium ion(GO:0005513) |
| 1.4 | 8.6 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 1.4 | 1.4 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
| 1.4 | 2.8 | GO:0070384 | Harderian gland development(GO:0070384) |
| 1.4 | 5.6 | GO:0006145 | purine nucleobase catabolic process(GO:0006145) |
| 1.4 | 5.6 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
| 1.4 | 12.6 | GO:0014832 | urinary bladder smooth muscle contraction(GO:0014832) |
| 1.4 | 2.8 | GO:1903181 | regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) |
| 1.4 | 5.5 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
| 1.4 | 6.8 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 1.4 | 2.7 | GO:0032910 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
| 1.4 | 4.1 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
| 1.4 | 4.1 | GO:0072180 | mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) mesonephric duct development(GO:0072177) mesonephric duct morphogenesis(GO:0072180) |
| 1.4 | 8.2 | GO:0032439 | endosome localization(GO:0032439) |
| 1.3 | 5.4 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
| 1.3 | 6.7 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
| 1.3 | 4.0 | GO:0006550 | isoleucine catabolic process(GO:0006550) |
| 1.3 | 4.0 | GO:0051892 | negative regulation of cardioblast differentiation(GO:0051892) |
| 1.3 | 27.7 | GO:0006491 | N-glycan processing(GO:0006491) |
| 1.3 | 6.6 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
| 1.3 | 7.9 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
| 1.3 | 6.5 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
| 1.3 | 7.8 | GO:0032803 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
| 1.3 | 5.2 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
| 1.3 | 1.3 | GO:0046101 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
| 1.3 | 9.0 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 1.3 | 3.8 | GO:0001757 | somite specification(GO:0001757) |
| 1.3 | 8.9 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 1.3 | 12.6 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 1.3 | 11.3 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
| 1.3 | 3.8 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
| 1.2 | 3.7 | GO:0001830 | trophectodermal cell fate commitment(GO:0001830) |
| 1.2 | 4.9 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
| 1.2 | 4.9 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
| 1.2 | 3.6 | GO:1903244 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 1.2 | 2.4 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
| 1.2 | 8.3 | GO:0098909 | regulation of cardiac muscle cell action potential involved in regulation of contraction(GO:0098909) |
| 1.2 | 4.7 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
| 1.2 | 7.0 | GO:0019695 | choline metabolic process(GO:0019695) |
| 1.2 | 5.9 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 1.2 | 2.3 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
| 1.2 | 3.5 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
| 1.2 | 6.9 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 1.1 | 3.4 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
| 1.1 | 5.7 | GO:0042045 | epithelial fluid transport(GO:0042045) |
| 1.1 | 5.7 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 1.1 | 6.7 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
| 1.1 | 3.4 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
| 1.1 | 1.1 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
| 1.1 | 7.8 | GO:0061718 | NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
| 1.1 | 4.5 | GO:0071287 | cellular response to manganese ion(GO:0071287) |
| 1.1 | 2.2 | GO:0032346 | positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) |
| 1.1 | 3.3 | GO:0006059 | hexitol metabolic process(GO:0006059) |
| 1.1 | 5.5 | GO:0036115 | fatty-acyl-CoA catabolic process(GO:0036115) |
| 1.1 | 1.1 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
| 1.1 | 5.4 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
| 1.1 | 1.1 | GO:0003274 | endocardial cushion fusion(GO:0003274) |
| 1.1 | 6.5 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 1.1 | 3.3 | GO:0009182 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) GDP metabolic process(GO:0046710) |
| 1.1 | 3.3 | GO:0061537 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 1.1 | 4.3 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
| 1.1 | 23.7 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
| 1.1 | 7.5 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 1.1 | 2.1 | GO:1903275 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) |
| 1.1 | 4.3 | GO:0010046 | response to mycotoxin(GO:0010046) |
| 1.1 | 2.1 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
| 1.0 | 9.4 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 1.0 | 4.2 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
| 1.0 | 13.5 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
| 1.0 | 1.0 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
| 1.0 | 8.3 | GO:0070314 | G1 to G0 transition(GO:0070314) |
| 1.0 | 3.1 | GO:0001505 | regulation of neurotransmitter levels(GO:0001505) |
| 1.0 | 12.3 | GO:0001553 | luteinization(GO:0001553) |
| 1.0 | 2.0 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
| 1.0 | 2.0 | GO:0035106 | operant conditioning(GO:0035106) |
| 1.0 | 6.1 | GO:0046645 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
| 1.0 | 45.1 | GO:0034605 | cellular response to heat(GO:0034605) |
| 1.0 | 2.0 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
| 1.0 | 4.0 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) |
| 1.0 | 4.9 | GO:0046689 | response to mercury ion(GO:0046689) |
| 1.0 | 2.0 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
| 1.0 | 1.0 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 1.0 | 10.7 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
| 1.0 | 2.9 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
| 1.0 | 6.8 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
| 1.0 | 2.9 | GO:2000016 | negative regulation of determination of dorsal identity(GO:2000016) |
| 1.0 | 1.0 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) |
| 1.0 | 3.8 | GO:0051866 | general adaptation syndrome(GO:0051866) |
| 1.0 | 1.9 | GO:0002339 | B cell selection(GO:0002339) |
| 0.9 | 13.3 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.9 | 2.8 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
| 0.9 | 3.7 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
| 0.9 | 10.2 | GO:0033005 | positive regulation of mast cell activation(GO:0033005) positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
| 0.9 | 0.9 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
| 0.9 | 6.5 | GO:0015824 | proline transport(GO:0015824) |
| 0.9 | 0.9 | GO:0002432 | granuloma formation(GO:0002432) |
| 0.9 | 2.7 | GO:0042636 | negative regulation of hair cycle(GO:0042636) negative regulation of hair follicle development(GO:0051799) |
| 0.9 | 4.5 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
| 0.9 | 1.8 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
| 0.9 | 2.7 | GO:0046022 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
| 0.9 | 3.6 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
| 0.9 | 19.7 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.9 | 11.5 | GO:1901898 | negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 0.9 | 4.4 | GO:0060591 | chondroblast differentiation(GO:0060591) |
| 0.9 | 6.2 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
| 0.9 | 2.6 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.9 | 2.6 | GO:0048298 | positive regulation of isotype switching to IgA isotypes(GO:0048298) |
| 0.9 | 2.6 | GO:0001964 | startle response(GO:0001964) |
| 0.9 | 1.7 | GO:0070459 | prolactin secretion(GO:0070459) |
| 0.9 | 0.9 | GO:0051665 | membrane raft localization(GO:0051665) |
| 0.9 | 2.6 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.9 | 2.6 | GO:0061075 | cerebral cortex GABAergic interneuron fate commitment(GO:0021893) regulation of photoreceptor cell differentiation(GO:0046532) negative regulation of photoreceptor cell differentiation(GO:0046533) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
| 0.9 | 2.6 | GO:0051542 | elastin biosynthetic process(GO:0051542) |
| 0.9 | 16.3 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
| 0.9 | 2.6 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
| 0.9 | 1.7 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.8 | 0.8 | GO:0032222 | regulation of synaptic transmission, cholinergic(GO:0032222) |
| 0.8 | 4.2 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
| 0.8 | 1.7 | GO:0031038 | myosin II filament organization(GO:0031038) regulation of myosin II filament organization(GO:0043519) |
| 0.8 | 0.8 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
| 0.8 | 15.8 | GO:0010543 | regulation of platelet activation(GO:0010543) |
| 0.8 | 3.3 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
| 0.8 | 0.8 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 0.8 | 3.3 | GO:0043589 | skin morphogenesis(GO:0043589) |
| 0.8 | 1.6 | GO:0015808 | L-alanine transport(GO:0015808) |
| 0.8 | 1.6 | GO:0060025 | regulation of synaptic activity(GO:0060025) |
| 0.8 | 5.7 | GO:0015862 | uridine transport(GO:0015862) |
| 0.8 | 0.8 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
| 0.8 | 4.9 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
| 0.8 | 4.9 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
| 0.8 | 2.4 | GO:0034035 | sulfate assimilation(GO:0000103) purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.8 | 2.4 | GO:1905247 | positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
| 0.8 | 2.4 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.8 | 0.8 | GO:2000277 | positive regulation of oxidative phosphorylation uncoupler activity(GO:2000277) |
| 0.8 | 0.8 | GO:0071220 | response to bacterial lipopeptide(GO:0070339) cellular response to bacterial lipoprotein(GO:0071220) cellular response to bacterial lipopeptide(GO:0071221) response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
| 0.8 | 1.6 | GO:0001821 | histamine secretion(GO:0001821) |
| 0.8 | 3.2 | GO:0002677 | negative regulation of chronic inflammatory response(GO:0002677) |
| 0.8 | 1.6 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
| 0.8 | 6.3 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
| 0.8 | 5.5 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
| 0.8 | 3.1 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
| 0.8 | 1.6 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
| 0.8 | 4.7 | GO:0090527 | actin filament reorganization(GO:0090527) |
| 0.8 | 1.6 | GO:0006566 | threonine metabolic process(GO:0006566) |
| 0.8 | 1.6 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
| 0.8 | 0.8 | GO:0090500 | endocardial cushion to mesenchymal transition(GO:0090500) |
| 0.8 | 3.1 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.8 | 5.4 | GO:0033034 | positive regulation of myeloid cell apoptotic process(GO:0033034) |
| 0.8 | 2.3 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
| 0.8 | 3.8 | GO:0042092 | type 2 immune response(GO:0042092) |
| 0.8 | 3.1 | GO:0032930 | positive regulation of superoxide anion generation(GO:0032930) |
| 0.8 | 1.5 | GO:0072071 | mesangial cell differentiation(GO:0072007) glomerular mesangial cell differentiation(GO:0072008) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) |
| 0.8 | 2.3 | GO:0050951 | sensory perception of temperature stimulus(GO:0050951) |
| 0.8 | 5.3 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
| 0.8 | 12.1 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.8 | 6.8 | GO:0014850 | response to muscle activity(GO:0014850) |
| 0.8 | 9.8 | GO:0033623 | regulation of integrin activation(GO:0033623) |
| 0.7 | 6.7 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
| 0.7 | 3.7 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
| 0.7 | 21.6 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
| 0.7 | 4.5 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
| 0.7 | 1.5 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.7 | 7.3 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
| 0.7 | 5.8 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
| 0.7 | 2.2 | GO:0040010 | positive regulation of growth rate(GO:0040010) |
| 0.7 | 6.5 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
| 0.7 | 2.2 | GO:0061744 | motor behavior(GO:0061744) |
| 0.7 | 9.4 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
| 0.7 | 1.4 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.7 | 8.6 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
| 0.7 | 4.2 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
| 0.7 | 5.7 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
| 0.7 | 5.6 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.7 | 0.7 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
| 0.7 | 1.4 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
| 0.7 | 1.4 | GO:0060913 | cardiac cell fate determination(GO:0060913) regulation of cardiac cell fate specification(GO:2000043) |
| 0.7 | 3.4 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.7 | 7.5 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
| 0.7 | 3.4 | GO:0044241 | lipid digestion(GO:0044241) |
| 0.7 | 1.3 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.7 | 4.0 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
| 0.7 | 10.1 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
| 0.7 | 2.7 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
| 0.7 | 6.0 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.7 | 4.6 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
| 0.7 | 2.0 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
| 0.7 | 4.6 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
| 0.7 | 6.6 | GO:0019243 | methylglyoxal metabolic process(GO:0009438) methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.7 | 2.6 | GO:0001550 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
| 0.7 | 2.6 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
| 0.7 | 6.5 | GO:0032625 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.6 | 3.2 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
| 0.6 | 9.1 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
| 0.6 | 1.9 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
| 0.6 | 4.5 | GO:0032261 | purine nucleotide salvage(GO:0032261) |
| 0.6 | 6.4 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
| 0.6 | 3.2 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
| 0.6 | 1.9 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
| 0.6 | 1.9 | GO:0071873 | response to norepinephrine(GO:0071873) |
| 0.6 | 1.3 | GO:0007412 | axon target recognition(GO:0007412) |
| 0.6 | 2.6 | GO:0070166 | enamel mineralization(GO:0070166) |
| 0.6 | 1.9 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
| 0.6 | 3.2 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
| 0.6 | 15.8 | GO:0015991 | ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
| 0.6 | 2.5 | GO:0033580 | protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
| 0.6 | 1.2 | GO:2001160 | regulation of histone H3-K79 methylation(GO:2001160) |
| 0.6 | 1.9 | GO:0035799 | ureter maturation(GO:0035799) |
| 0.6 | 2.5 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.6 | 4.3 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
| 0.6 | 8.6 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
| 0.6 | 1.8 | GO:0097501 | stress response to metal ion(GO:0097501) |
| 0.6 | 0.6 | GO:1904008 | response to monosodium glutamate(GO:1904008) cellular response to monosodium glutamate(GO:1904009) |
| 0.6 | 22.5 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.6 | 1.2 | GO:0070200 | establishment of protein localization to telomere(GO:0070200) |
| 0.6 | 1.8 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.6 | 3.0 | GO:1904995 | negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
| 0.6 | 2.4 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
| 0.6 | 3.0 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
| 0.6 | 6.6 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
| 0.6 | 1.8 | GO:0071929 | alpha-tubulin acetylation(GO:0071929) |
| 0.6 | 1.2 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.6 | 2.4 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
| 0.6 | 3.0 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
| 0.6 | 3.0 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 0.6 | 1.2 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
| 0.6 | 1.2 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
| 0.6 | 3.0 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
| 0.6 | 4.1 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.6 | 7.0 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.6 | 1.2 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 0.6 | 2.3 | GO:1904529 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 0.6 | 1.7 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
| 0.6 | 1.7 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
| 0.6 | 2.3 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
| 0.6 | 1.7 | GO:0009174 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
| 0.6 | 2.3 | GO:0015888 | thiamine transport(GO:0015888) |
| 0.6 | 2.3 | GO:0010454 | negative regulation of cell fate commitment(GO:0010454) |
| 0.6 | 2.9 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
| 0.6 | 2.8 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.6 | 1.1 | GO:0032847 | regulation of cellular pH reduction(GO:0032847) |
| 0.6 | 6.8 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
| 0.6 | 1.1 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
| 0.6 | 4.5 | GO:0032274 | gonadotropin secretion(GO:0032274) |
| 0.6 | 3.4 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
| 0.6 | 0.6 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
| 0.6 | 2.8 | GO:1990034 | calcium ion export from cell(GO:1990034) |
| 0.6 | 2.2 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
| 0.6 | 1.1 | GO:0008272 | sulfate transport(GO:0008272) |
| 0.6 | 2.2 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.5 | 1.6 | GO:0051126 | negative regulation of actin nucleation(GO:0051126) |
| 0.5 | 15.9 | GO:0018345 | protein palmitoylation(GO:0018345) |
| 0.5 | 1.1 | GO:0050975 | sensory perception of touch(GO:0050975) |
| 0.5 | 1.6 | GO:0006507 | GPI anchor release(GO:0006507) |
| 0.5 | 1.6 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.5 | 1.6 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
| 0.5 | 9.8 | GO:0048268 | clathrin coat assembly(GO:0048268) |
| 0.5 | 0.5 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
| 0.5 | 2.7 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.5 | 4.3 | GO:0097421 | liver regeneration(GO:0097421) |
| 0.5 | 2.7 | GO:1904721 | regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) negative regulation of immunoglobulin secretion(GO:0051025) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
| 0.5 | 3.7 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
| 0.5 | 2.6 | GO:0007351 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
| 0.5 | 0.5 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
| 0.5 | 2.1 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
| 0.5 | 17.7 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) |
| 0.5 | 1.6 | GO:0019236 | response to pheromone(GO:0019236) |
| 0.5 | 2.1 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
| 0.5 | 0.5 | GO:1904350 | regulation of protein catabolic process in the vacuole(GO:1904350) |
| 0.5 | 0.5 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.5 | 3.1 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
| 0.5 | 1.5 | GO:0018343 | protein farnesylation(GO:0018343) |
| 0.5 | 9.2 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.5 | 4.6 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
| 0.5 | 2.5 | GO:0055095 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
| 0.5 | 1.5 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.5 | 4.5 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.5 | 2.5 | GO:0043615 | astrocyte cell migration(GO:0043615) |
| 0.5 | 1.0 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
| 0.5 | 2.5 | GO:0080184 | response to stilbenoid(GO:0035634) response to phenylpropanoid(GO:0080184) |
| 0.5 | 10.3 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
| 0.5 | 4.9 | GO:0009651 | response to salt stress(GO:0009651) |
| 0.5 | 2.9 | GO:0071494 | cellular response to UV-C(GO:0071494) |
| 0.5 | 1.5 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.5 | 4.4 | GO:0006020 | inositol metabolic process(GO:0006020) |
| 0.5 | 11.2 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
| 0.5 | 0.5 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
| 0.5 | 7.8 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
| 0.5 | 1.0 | GO:0015886 | heme transport(GO:0015886) |
| 0.5 | 7.2 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.5 | 1.0 | GO:0042368 | negative regulation of vitamin D biosynthetic process(GO:0010957) vitamin D biosynthetic process(GO:0042368) negative regulation of vitamin metabolic process(GO:0046137) regulation of vitamin D biosynthetic process(GO:0060556) |
| 0.5 | 1.9 | GO:0050913 | sensory perception of bitter taste(GO:0050913) |
| 0.5 | 3.4 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
| 0.5 | 1.4 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
| 0.5 | 7.2 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
| 0.5 | 1.0 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
| 0.5 | 1.0 | GO:0010896 | regulation of triglyceride catabolic process(GO:0010896) |
| 0.5 | 4.7 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
| 0.5 | 15.5 | GO:0045022 | early endosome to late endosome transport(GO:0045022) |
| 0.5 | 1.9 | GO:0006751 | glutathione catabolic process(GO:0006751) |
| 0.5 | 5.6 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
| 0.5 | 0.5 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
| 0.5 | 1.4 | GO:0006226 | dUMP biosynthetic process(GO:0006226) |
| 0.5 | 1.4 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
| 0.5 | 1.9 | GO:0072185 | pyruvate transport(GO:0006848) canonical Wnt signaling pathway involved in positive regulation of wound healing(GO:0044330) lactic acid secretion(GO:0046722) metanephric cap development(GO:0072185) metanephric cap morphogenesis(GO:0072186) metanephric cap mesenchymal cell proliferation involved in metanephros development(GO:0090094) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 0.5 | 1.9 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
| 0.5 | 0.5 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
| 0.5 | 1.4 | GO:2000744 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 0.5 | 4.6 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
| 0.5 | 5.0 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
| 0.5 | 3.6 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
| 0.5 | 1.4 | GO:0060437 | lung growth(GO:0060437) |
| 0.5 | 5.0 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.5 | 1.4 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
| 0.5 | 1.4 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
| 0.5 | 0.5 | GO:0015810 | aspartate transport(GO:0015810) |
| 0.4 | 0.4 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
| 0.4 | 0.9 | GO:0010039 | response to iron ion(GO:0010039) |
| 0.4 | 0.9 | GO:0046541 | saliva secretion(GO:0046541) |
| 0.4 | 4.0 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
| 0.4 | 0.9 | GO:1904580 | regulation of intracellular mRNA localization(GO:1904580) |
| 0.4 | 2.2 | GO:0072683 | T cell extravasation(GO:0072683) |
| 0.4 | 2.6 | GO:0031639 | plasminogen activation(GO:0031639) |
| 0.4 | 1.3 | GO:0090646 | mitochondrial RNA 3'-end processing(GO:0000965) mitochondrial tRNA processing(GO:0090646) |
| 0.4 | 1.7 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
| 0.4 | 2.6 | GO:0001765 | membrane raft assembly(GO:0001765) |
| 0.4 | 11.2 | GO:0048678 | response to axon injury(GO:0048678) |
| 0.4 | 2.2 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
| 0.4 | 0.9 | GO:0051933 | amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
| 0.4 | 1.7 | GO:0050861 | regulation of glial cell apoptotic process(GO:0034350) positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.4 | 1.3 | GO:0060056 | mammary gland involution(GO:0060056) |
| 0.4 | 1.7 | GO:0019348 | dolichol metabolic process(GO:0019348) |
| 0.4 | 3.0 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 0.4 | 3.0 | GO:0048484 | enteric nervous system development(GO:0048484) |
| 0.4 | 2.1 | GO:0002317 | plasma cell differentiation(GO:0002317) |
| 0.4 | 1.7 | GO:0048713 | regulation of oligodendrocyte differentiation(GO:0048713) |
| 0.4 | 2.9 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.4 | 5.0 | GO:0045475 | locomotor rhythm(GO:0045475) |
| 0.4 | 1.7 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
| 0.4 | 0.8 | GO:2000812 | regulation of barbed-end actin filament capping(GO:2000812) |
| 0.4 | 3.3 | GO:0071816 | tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
| 0.4 | 0.8 | GO:0034287 | ectoderm formation(GO:0001705) detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
| 0.4 | 1.6 | GO:1904451 | regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904451) positive regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904453) |
| 0.4 | 4.9 | GO:0001916 | positive regulation of T cell mediated cytotoxicity(GO:0001916) |
| 0.4 | 2.4 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
| 0.4 | 0.4 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
| 0.4 | 1.6 | GO:0046898 | response to cycloheximide(GO:0046898) |
| 0.4 | 4.0 | GO:0015701 | bicarbonate transport(GO:0015701) |
| 0.4 | 0.8 | GO:1902915 | regulation of chromatin assembly(GO:0010847) negative regulation of protein import into nucleus, translocation(GO:0033159) negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
| 0.4 | 0.8 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
| 0.4 | 1.2 | GO:0016240 | autophagosome docking(GO:0016240) |
| 0.4 | 3.5 | GO:0098907 | regulation of SA node cell action potential(GO:0098907) |
| 0.4 | 1.6 | GO:0042756 | drinking behavior(GO:0042756) |
| 0.4 | 1.2 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) |
| 0.4 | 1.2 | GO:0031657 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
| 0.4 | 5.4 | GO:0022401 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
| 0.4 | 1.9 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.4 | 1.2 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
| 0.4 | 0.8 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
| 0.4 | 0.4 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
| 0.4 | 1.1 | GO:0031645 | negative regulation of myelination(GO:0031642) negative regulation of neurological system process(GO:0031645) |
| 0.4 | 3.4 | GO:1903078 | positive regulation of protein localization to plasma membrane(GO:1903078) |
| 0.4 | 2.3 | GO:0051958 | methotrexate transport(GO:0051958) reduced folate transmembrane transport(GO:0098838) |
| 0.4 | 2.3 | GO:0016114 | terpenoid biosynthetic process(GO:0016114) |
| 0.4 | 1.1 | GO:0006710 | androgen catabolic process(GO:0006710) |
| 0.4 | 4.1 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
| 0.4 | 5.2 | GO:0051639 | actin filament network formation(GO:0051639) |
| 0.4 | 3.3 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
| 0.4 | 8.9 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.4 | 1.1 | GO:0015747 | urate transport(GO:0015747) |
| 0.4 | 27.2 | GO:1903749 | positive regulation of establishment of protein localization to mitochondrion(GO:1903749) |
| 0.4 | 0.7 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
| 0.4 | 0.7 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
| 0.4 | 0.7 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
| 0.4 | 2.9 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
| 0.4 | 2.2 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
| 0.4 | 1.1 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
| 0.4 | 2.9 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 0.4 | 6.5 | GO:0034389 | lipid particle organization(GO:0034389) |
| 0.4 | 2.9 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
| 0.4 | 2.9 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.4 | 1.4 | GO:0019287 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) isopentenyl diphosphate metabolic process(GO:0046490) |
| 0.4 | 3.2 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
| 0.4 | 0.4 | GO:1901228 | positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
| 0.4 | 1.4 | GO:0015786 | UDP-glucose transport(GO:0015786) |
| 0.4 | 3.2 | GO:0038203 | TORC2 signaling(GO:0038203) |
| 0.4 | 0.7 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
| 0.4 | 1.4 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
| 0.4 | 0.7 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 0.4 | 1.4 | GO:0015871 | choline transport(GO:0015871) |
| 0.3 | 3.1 | GO:0030049 | muscle filament sliding(GO:0030049) |
| 0.3 | 0.3 | GO:1903719 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 0.3 | 6.2 | GO:0097120 | receptor localization to synapse(GO:0097120) |
| 0.3 | 1.0 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
| 0.3 | 2.7 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
| 0.3 | 1.0 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.3 | 1.0 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
| 0.3 | 2.7 | GO:0099640 | axo-dendritic protein transport(GO:0099640) |
| 0.3 | 3.0 | GO:0007567 | parturition(GO:0007567) |
| 0.3 | 8.1 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.3 | 5.7 | GO:0010107 | potassium ion import(GO:0010107) |
| 0.3 | 2.3 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
| 0.3 | 0.7 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
| 0.3 | 2.3 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
| 0.3 | 3.0 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) positive regulation of neutrophil chemotaxis(GO:0090023) |
| 0.3 | 1.0 | GO:1901203 | positive regulation of extracellular matrix assembly(GO:1901203) |
| 0.3 | 0.3 | GO:0031133 | regulation of axon diameter(GO:0031133) |
| 0.3 | 1.7 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.3 | 1.3 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
| 0.3 | 6.6 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
| 0.3 | 3.0 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
| 0.3 | 2.3 | GO:0034390 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
| 0.3 | 0.7 | GO:1900120 | regulation of receptor binding(GO:1900120) |
| 0.3 | 0.7 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.3 | 6.9 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.3 | 1.3 | GO:0051205 | protein insertion into membrane(GO:0051205) |
| 0.3 | 1.6 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
| 0.3 | 1.6 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
| 0.3 | 13.8 | GO:1901379 | regulation of potassium ion transmembrane transport(GO:1901379) |
| 0.3 | 0.6 | GO:0033762 | response to glucagon(GO:0033762) |
| 0.3 | 1.9 | GO:0033006 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
| 0.3 | 5.1 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.3 | 2.2 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 0.3 | 3.8 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.3 | 0.6 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
| 0.3 | 0.6 | GO:0007128 | meiotic prophase I(GO:0007128) prophase(GO:0051324) |
| 0.3 | 0.9 | GO:2000319 | negative regulation of T-helper 17 type immune response(GO:2000317) regulation of T-helper 17 cell differentiation(GO:2000319) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
| 0.3 | 1.2 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
| 0.3 | 1.8 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
| 0.3 | 1.2 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
| 0.3 | 0.9 | GO:0006667 | sphinganine metabolic process(GO:0006667) lipophagy(GO:0061724) regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
| 0.3 | 1.5 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
| 0.3 | 0.9 | GO:0003418 | growth plate cartilage chondrocyte differentiation(GO:0003418) |
| 0.3 | 1.5 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
| 0.3 | 11.2 | GO:0045806 | negative regulation of endocytosis(GO:0045806) |
| 0.3 | 1.2 | GO:0071318 | cellular response to ATP(GO:0071318) |
| 0.3 | 0.9 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
| 0.3 | 1.8 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
| 0.3 | 8.0 | GO:0007020 | microtubule nucleation(GO:0007020) |
| 0.3 | 1.8 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.3 | 3.2 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
| 0.3 | 1.2 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
| 0.3 | 0.6 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
| 0.3 | 0.9 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) |
| 0.3 | 0.3 | GO:0015870 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
| 0.3 | 0.6 | GO:0036089 | cleavage furrow formation(GO:0036089) |
| 0.3 | 0.9 | GO:0000448 | cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000448) |
| 0.3 | 0.9 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
| 0.3 | 1.7 | GO:1903961 | positive regulation of anion transmembrane transport(GO:1903961) |
| 0.3 | 0.9 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
| 0.3 | 7.1 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
| 0.3 | 0.8 | GO:0060217 | positive regulation of chromatin assembly or disassembly(GO:0045799) hemangioblast cell differentiation(GO:0060217) |
| 0.3 | 2.5 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
| 0.3 | 0.6 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
| 0.3 | 1.7 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
| 0.3 | 0.8 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
| 0.3 | 29.6 | GO:0016579 | protein deubiquitination(GO:0016579) |
| 0.3 | 1.7 | GO:0006108 | malate metabolic process(GO:0006108) |
| 0.3 | 1.9 | GO:0007296 | vitellogenesis(GO:0007296) |
| 0.3 | 6.6 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
| 0.3 | 1.4 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.3 | 0.6 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
| 0.3 | 6.3 | GO:0045921 | positive regulation of exocytosis(GO:0045921) |
| 0.3 | 0.3 | GO:0009826 | unidimensional cell growth(GO:0009826) |
| 0.3 | 5.9 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.3 | 1.9 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
| 0.3 | 2.7 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.3 | 2.7 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
| 0.3 | 5.9 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
| 0.3 | 8.2 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
| 0.3 | 1.1 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.3 | 0.5 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
| 0.3 | 5.3 | GO:0008340 | determination of adult lifespan(GO:0008340) |
| 0.3 | 0.8 | GO:0032402 | melanosome transport(GO:0032402) |
| 0.3 | 1.6 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.3 | 0.8 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
| 0.3 | 0.5 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.3 | 0.8 | GO:0019085 | early viral transcription(GO:0019085) |
| 0.3 | 2.3 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
| 0.3 | 0.8 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
| 0.3 | 2.0 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
| 0.3 | 0.8 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
| 0.3 | 0.8 | GO:0019659 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
| 0.2 | 1.0 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.2 | 0.7 | GO:0006624 | vacuolar protein processing(GO:0006624) |
| 0.2 | 0.5 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
| 0.2 | 0.7 | GO:0042560 | 10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 0.2 | 0.5 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
| 0.2 | 0.5 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
| 0.2 | 0.7 | GO:0051182 | coenzyme transport(GO:0051182) |
| 0.2 | 0.5 | GO:0010877 | lipid transport involved in lipid storage(GO:0010877) |
| 0.2 | 1.9 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) negative regulation of protein folding(GO:1903333) |
| 0.2 | 1.4 | GO:0016322 | neuron remodeling(GO:0016322) |
| 0.2 | 0.5 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
| 0.2 | 0.5 | GO:1902527 | regulation of protein monoubiquitination(GO:1902525) positive regulation of protein monoubiquitination(GO:1902527) |
| 0.2 | 1.7 | GO:0016584 | nucleosome positioning(GO:0016584) |
| 0.2 | 0.7 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
| 0.2 | 1.7 | GO:0006561 | proline biosynthetic process(GO:0006561) |
| 0.2 | 1.0 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
| 0.2 | 1.2 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.2 | 2.1 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.2 | 1.2 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.2 | 0.7 | GO:0030974 | thiamine pyrophosphate transport(GO:0030974) |
| 0.2 | 0.9 | GO:0035315 | hair cell differentiation(GO:0035315) auditory receptor cell differentiation(GO:0042491) |
| 0.2 | 5.7 | GO:0009303 | rRNA transcription(GO:0009303) |
| 0.2 | 1.1 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.2 | 0.7 | GO:0048254 | snoRNA localization(GO:0048254) |
| 0.2 | 2.3 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.2 | 0.7 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
| 0.2 | 1.1 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
| 0.2 | 1.3 | GO:0036296 | cellular response to increased oxygen levels(GO:0036295) response to increased oxygen levels(GO:0036296) |
| 0.2 | 0.7 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.2 | 0.7 | GO:0071918 | urea transmembrane transport(GO:0071918) |
| 0.2 | 0.4 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
| 0.2 | 2.4 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
| 0.2 | 3.3 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) |
| 0.2 | 1.5 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
| 0.2 | 0.2 | GO:0060253 | negative regulation of glial cell proliferation(GO:0060253) |
| 0.2 | 0.9 | GO:2000525 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
| 0.2 | 1.1 | GO:0002347 | response to tumor cell(GO:0002347) |
| 0.2 | 0.6 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.2 | 3.2 | GO:1901984 | negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
| 0.2 | 1.9 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 0.2 | 2.5 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
| 0.2 | 1.3 | GO:0097473 | cellular response to light intensity(GO:0071484) cellular response to high light intensity(GO:0071486) retinal rod cell apoptotic process(GO:0097473) |
| 0.2 | 1.0 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
| 0.2 | 0.4 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
| 0.2 | 0.4 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 0.2 | 0.6 | GO:0098928 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
| 0.2 | 0.6 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
| 0.2 | 1.0 | GO:0005980 | polysaccharide catabolic process(GO:0000272) glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
| 0.2 | 0.8 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
| 0.2 | 6.4 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.2 | 2.3 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.2 | 1.8 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
| 0.2 | 1.0 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 0.2 | 0.2 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) |
| 0.2 | 0.2 | GO:1902284 | axon extension involved in axon guidance(GO:0048846) neuron projection extension involved in neuron projection guidance(GO:1902284) |
| 0.2 | 0.6 | GO:0015868 | purine nucleotide transport(GO:0015865) purine ribonucleotide transport(GO:0015868) |
| 0.2 | 1.8 | GO:1901070 | GTP biosynthetic process(GO:0006183) guanosine-containing compound biosynthetic process(GO:1901070) |
| 0.2 | 1.6 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
| 0.2 | 0.6 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
| 0.2 | 0.8 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
| 0.2 | 0.6 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
| 0.2 | 1.2 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
| 0.2 | 0.2 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
| 0.2 | 14.4 | GO:0035308 | negative regulation of protein dephosphorylation(GO:0035308) |
| 0.2 | 0.2 | GO:0001787 | natural killer cell proliferation(GO:0001787) NK T cell activation(GO:0051132) |
| 0.2 | 1.7 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
| 0.2 | 0.4 | GO:0060745 | mammary gland branching involved in pregnancy(GO:0060745) |
| 0.2 | 0.6 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
| 0.2 | 1.7 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
| 0.2 | 0.4 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
| 0.2 | 2.7 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
| 0.2 | 0.9 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
| 0.2 | 1.1 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
| 0.2 | 0.4 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.2 | 1.3 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
| 0.2 | 0.4 | GO:0072103 | renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
| 0.2 | 0.2 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
| 0.2 | 0.4 | GO:0006106 | fumarate metabolic process(GO:0006106) |
| 0.2 | 6.8 | GO:0010812 | negative regulation of cell-substrate adhesion(GO:0010812) |
| 0.2 | 0.7 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
| 0.2 | 1.3 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
| 0.2 | 0.7 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
| 0.2 | 0.2 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
| 0.2 | 0.9 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.2 | 1.4 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
| 0.2 | 0.5 | GO:1904528 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) positive regulation of microtubule binding(GO:1904528) |
| 0.2 | 2.3 | GO:0008206 | bile acid metabolic process(GO:0008206) |
| 0.2 | 1.2 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.2 | 2.6 | GO:0048240 | sperm capacitation(GO:0048240) |
| 0.2 | 1.4 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
| 0.2 | 0.7 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.2 | 0.9 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.2 | 1.1 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
| 0.2 | 0.3 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
| 0.2 | 0.5 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
| 0.2 | 1.0 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
| 0.2 | 3.6 | GO:0034340 | response to type I interferon(GO:0034340) |
| 0.2 | 0.3 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.2 | 0.7 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
| 0.2 | 0.5 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
| 0.2 | 1.2 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
| 0.2 | 1.7 | GO:0006465 | signal peptide processing(GO:0006465) |
| 0.2 | 0.5 | GO:0042182 | ketone catabolic process(GO:0042182) |
| 0.2 | 1.3 | GO:2000035 | regulation of stem cell division(GO:2000035) |
| 0.2 | 0.7 | GO:0046688 | response to copper ion(GO:0046688) |
| 0.2 | 0.8 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
| 0.2 | 0.2 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) |
| 0.2 | 1.3 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
| 0.2 | 8.6 | GO:0022900 | electron transport chain(GO:0022900) |
| 0.2 | 1.6 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
| 0.2 | 1.1 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
| 0.2 | 0.7 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
| 0.2 | 0.3 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
| 0.2 | 0.5 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
| 0.2 | 0.3 | GO:1901550 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
| 0.2 | 0.6 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
| 0.2 | 0.5 | GO:0001955 | blood vessel maturation(GO:0001955) |
| 0.2 | 0.5 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
| 0.2 | 1.3 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
| 0.2 | 0.3 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
| 0.2 | 0.6 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
| 0.2 | 0.5 | GO:0071544 | diphosphoinositol polyphosphate catabolic process(GO:0071544) |
| 0.2 | 0.8 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
| 0.2 | 0.3 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
| 0.2 | 0.5 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
| 0.2 | 2.9 | GO:0002548 | monocyte chemotaxis(GO:0002548) |
| 0.2 | 0.6 | GO:1903975 | regulation of glial cell migration(GO:1903975) |
| 0.2 | 2.3 | GO:0097178 | ruffle assembly(GO:0097178) |
| 0.2 | 0.5 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
| 0.2 | 0.3 | GO:0045358 | negative regulation of interferon-beta biosynthetic process(GO:0045358) |
| 0.2 | 1.7 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.1 | 0.3 | GO:0099527 | postsynapse to nucleus signaling pathway(GO:0099527) |
| 0.1 | 0.9 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
| 0.1 | 0.6 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
| 0.1 | 0.9 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
| 0.1 | 0.3 | GO:0070343 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
| 0.1 | 0.9 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
| 0.1 | 1.3 | GO:0010661 | positive regulation of muscle cell apoptotic process(GO:0010661) |
| 0.1 | 0.7 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
| 0.1 | 2.4 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
| 0.1 | 0.4 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
| 0.1 | 0.3 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
| 0.1 | 0.6 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
| 0.1 | 1.4 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
| 0.1 | 1.0 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
| 0.1 | 0.5 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.1 | 7.9 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
| 0.1 | 0.5 | GO:0097320 | membrane tubulation(GO:0097320) |
| 0.1 | 0.3 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
| 0.1 | 0.8 | GO:0001980 | regulation of systemic arterial blood pressure by ischemic conditions(GO:0001980) |
| 0.1 | 0.5 | GO:0006071 | glycerol metabolic process(GO:0006071) |
| 0.1 | 1.1 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
| 0.1 | 0.8 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
| 0.1 | 0.4 | GO:0006013 | mannose metabolic process(GO:0006013) |
| 0.1 | 6.0 | GO:0006611 | protein export from nucleus(GO:0006611) |
| 0.1 | 2.0 | GO:0014002 | astrocyte development(GO:0014002) |
| 0.1 | 0.5 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.1 | 0.1 | GO:1902869 | regulation of amacrine cell differentiation(GO:1902869) |
| 0.1 | 0.4 | GO:0046016 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) positive regulation of transcription by glucose(GO:0046016) |
| 0.1 | 0.5 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
| 0.1 | 0.3 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
| 0.1 | 0.1 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.1 | 0.3 | GO:0021933 | radial glia guided migration of cerebellar granule cell(GO:0021933) |
| 0.1 | 0.4 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.1 | 1.5 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
| 0.1 | 0.3 | GO:0030043 | actin filament fragmentation(GO:0030043) |
| 0.1 | 0.3 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.1 | 0.6 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
| 0.1 | 0.4 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
| 0.1 | 0.5 | GO:0051798 | regulation of hair follicle development(GO:0051797) positive regulation of hair follicle development(GO:0051798) |
| 0.1 | 0.9 | GO:0035994 | response to muscle stretch(GO:0035994) |
| 0.1 | 0.5 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
| 0.1 | 0.1 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 0.1 | 0.5 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
| 0.1 | 1.0 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
| 0.1 | 2.2 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
| 0.1 | 0.4 | GO:0042275 | error-free postreplication DNA repair(GO:0042275) |
| 0.1 | 2.2 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
| 0.1 | 1.1 | GO:0032060 | bleb assembly(GO:0032060) |
| 0.1 | 0.5 | GO:0032735 | positive regulation of interleukin-12 production(GO:0032735) |
| 0.1 | 1.8 | GO:0006111 | regulation of gluconeogenesis(GO:0006111) |
| 0.1 | 2.6 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
| 0.1 | 0.8 | GO:0016074 | snoRNA metabolic process(GO:0016074) snoRNA processing(GO:0043144) |
| 0.1 | 1.2 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
| 0.1 | 8.3 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) |
| 0.1 | 0.1 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
| 0.1 | 3.7 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
| 0.1 | 1.0 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.1 | 1.0 | GO:0060088 | auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
| 0.1 | 0.6 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
| 0.1 | 0.3 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
| 0.1 | 0.7 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
| 0.1 | 1.6 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
| 0.1 | 0.1 | GO:1904152 | regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
| 0.1 | 0.7 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
| 0.1 | 1.7 | GO:0006818 | hydrogen transport(GO:0006818) |
| 0.1 | 0.8 | GO:0070475 | rRNA base methylation(GO:0070475) |
| 0.1 | 0.2 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) |
| 0.1 | 0.4 | GO:0033089 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
| 0.1 | 0.3 | GO:0032790 | ribosome disassembly(GO:0032790) |
| 0.1 | 6.2 | GO:0051865 | protein autoubiquitination(GO:0051865) |
| 0.1 | 0.4 | GO:0060312 | regulation of blood vessel remodeling(GO:0060312) |
| 0.1 | 1.1 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
| 0.1 | 0.9 | GO:0046460 | triglyceride biosynthetic process(GO:0019432) neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
| 0.1 | 0.4 | GO:0042311 | vasodilation(GO:0042311) |
| 0.1 | 0.3 | GO:0023035 | CD40 signaling pathway(GO:0023035) regulation of CD40 signaling pathway(GO:2000348) |
| 0.1 | 0.7 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
| 0.1 | 0.2 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
| 0.1 | 0.8 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
| 0.1 | 1.7 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.1 | 0.8 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
| 0.1 | 0.4 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.1 | 0.3 | GO:0008343 | adult feeding behavior(GO:0008343) |
| 0.1 | 0.2 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
| 0.1 | 0.3 | GO:0010820 | regulation of T cell chemotaxis(GO:0010819) positive regulation of T cell chemotaxis(GO:0010820) |
| 0.1 | 0.7 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
| 0.1 | 0.6 | GO:0042572 | retinol metabolic process(GO:0042572) |
| 0.1 | 0.7 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
| 0.1 | 0.4 | GO:0050812 | regulation of acyl-CoA biosynthetic process(GO:0050812) |
| 0.1 | 0.3 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
| 0.1 | 0.6 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.1 | 0.3 | GO:1900060 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.1 | 0.3 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.1 | 0.5 | GO:0045019 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
| 0.1 | 5.6 | GO:0042742 | defense response to bacterium(GO:0042742) |
| 0.1 | 0.1 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
| 0.1 | 0.4 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
| 0.1 | 0.5 | GO:1902047 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
| 0.1 | 1.1 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
| 0.1 | 2.4 | GO:0051453 | regulation of intracellular pH(GO:0051453) |
| 0.1 | 1.3 | GO:1901655 | cellular response to ketone(GO:1901655) |
| 0.1 | 1.1 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
| 0.1 | 0.3 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
| 0.1 | 0.3 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.1 | 0.2 | GO:1902950 | regulation of dendritic spine maintenance(GO:1902950) |
| 0.1 | 0.5 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.1 | 0.4 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 0.1 | 0.2 | GO:0043486 | histone exchange(GO:0043486) |
| 0.1 | 1.2 | GO:1900077 | negative regulation of cellular response to insulin stimulus(GO:1900077) |
| 0.1 | 0.4 | GO:0022403 | cell cycle phase(GO:0022403) |
| 0.1 | 0.3 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
| 0.1 | 0.9 | GO:0035418 | protein localization to synapse(GO:0035418) |
| 0.1 | 0.3 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
| 0.1 | 0.2 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.1 | 0.5 | GO:0051788 | response to misfolded protein(GO:0051788) cellular response to misfolded protein(GO:0071218) |
| 0.1 | 0.3 | GO:0048820 | hair follicle maturation(GO:0048820) |
| 0.1 | 0.2 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
| 0.1 | 0.2 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
| 0.1 | 0.4 | GO:0002115 | store-operated calcium entry(GO:0002115) |
| 0.1 | 3.2 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
| 0.1 | 0.3 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
| 0.1 | 3.8 | GO:0030032 | lamellipodium assembly(GO:0030032) |
| 0.1 | 0.2 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
| 0.1 | 0.4 | GO:0032298 | positive regulation of DNA-dependent DNA replication initiation(GO:0032298) |
| 0.1 | 0.3 | GO:0072272 | pattern specification involved in metanephros development(GO:0072268) proximal/distal pattern formation involved in metanephric nephron development(GO:0072272) |
| 0.1 | 0.4 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
| 0.1 | 0.5 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
| 0.1 | 3.9 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
| 0.1 | 0.1 | GO:0042097 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) |
| 0.1 | 0.5 | GO:0060768 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
| 0.1 | 0.6 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.1 | 0.1 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
| 0.1 | 0.8 | GO:1904816 | regulation of protein localization to chromosome, telomeric region(GO:1904814) positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
| 0.1 | 0.3 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.1 | 0.2 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
| 0.1 | 0.3 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
| 0.1 | 0.4 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
| 0.1 | 0.8 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.1 | 0.4 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.1 | 0.5 | GO:0031063 | regulation of histone deacetylation(GO:0031063) |
| 0.1 | 0.4 | GO:0061515 | myeloid cell development(GO:0061515) |
| 0.1 | 3.9 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
| 0.1 | 0.3 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
| 0.1 | 0.1 | GO:0042730 | fibrinolysis(GO:0042730) |
| 0.1 | 0.4 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
| 0.1 | 0.3 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
| 0.1 | 0.1 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
| 0.1 | 0.4 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
| 0.1 | 1.8 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
| 0.1 | 0.2 | GO:1901911 | diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 0.1 | 0.2 | GO:0090494 | catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
| 0.1 | 0.1 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
| 0.1 | 0.2 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
| 0.1 | 0.3 | GO:0048266 | behavioral response to pain(GO:0048266) |
| 0.1 | 0.3 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.1 | 0.5 | GO:0000154 | rRNA modification(GO:0000154) |
| 0.1 | 0.2 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
| 0.1 | 0.5 | GO:0035640 | exploration behavior(GO:0035640) |
| 0.1 | 0.2 | GO:1903214 | regulation of protein targeting to mitochondrion(GO:1903214) |
| 0.1 | 0.3 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.1 | 0.5 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
| 0.1 | 0.2 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
| 0.0 | 0.1 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
| 0.0 | 0.6 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) branched-chain amino acid catabolic process(GO:0009083) |
| 0.0 | 0.3 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.0 | 1.0 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
| 0.0 | 0.6 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
| 0.0 | 0.5 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
| 0.0 | 0.3 | GO:0006265 | DNA topological change(GO:0006265) |
| 0.0 | 0.3 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
| 0.0 | 0.4 | GO:0032094 | response to food(GO:0032094) |
| 0.0 | 0.2 | GO:0046415 | urate metabolic process(GO:0046415) |
| 0.0 | 0.3 | GO:0048311 | mitochondrion distribution(GO:0048311) |
| 0.0 | 0.2 | GO:0039532 | negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
| 0.0 | 0.3 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.0 | 0.4 | GO:0009268 | response to pH(GO:0009268) |
| 0.0 | 0.2 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
| 0.0 | 0.3 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
| 0.0 | 0.9 | GO:0006672 | ceramide metabolic process(GO:0006672) |
| 0.0 | 0.2 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
| 0.0 | 0.3 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
| 0.0 | 1.1 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.0 | 0.1 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
| 0.0 | 0.0 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
| 0.0 | 0.1 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
| 0.0 | 0.1 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.0 | 0.5 | GO:0042026 | protein refolding(GO:0042026) |
| 0.0 | 0.0 | GO:0000429 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) carbon catabolite activation of transcription(GO:0045991) |
| 0.0 | 0.1 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
| 0.0 | 0.6 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
| 0.0 | 0.3 | GO:0042133 | neurotransmitter metabolic process(GO:0042133) |
| 0.0 | 0.1 | GO:2001012 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
| 0.0 | 1.1 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
| 0.0 | 0.2 | GO:0050687 | negative regulation of defense response to virus(GO:0050687) |
| 0.0 | 0.3 | GO:0097352 | autophagosome maturation(GO:0097352) |
| 0.0 | 0.1 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
| 0.0 | 0.3 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
| 0.0 | 0.3 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.0 | 0.1 | GO:0036451 | cap mRNA methylation(GO:0036451) |
| 0.0 | 0.4 | GO:0007032 | endosome organization(GO:0007032) |
| 0.0 | 0.1 | GO:0006817 | phosphate ion transport(GO:0006817) |
| 0.0 | 0.3 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.0 | 0.1 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
| 0.0 | 0.2 | GO:0006301 | postreplication repair(GO:0006301) |
| 0.0 | 0.2 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.0 | 0.1 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.0 | 0.1 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 0.0 | 0.1 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
| 0.0 | 0.1 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.0 | 0.0 | GO:0031554 | regulation of DNA-templated transcription, termination(GO:0031554) |
| 0.0 | 0.1 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.0 | 1.5 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
| 0.0 | 0.0 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
| 0.0 | 0.4 | GO:0046677 | response to antibiotic(GO:0046677) |
| 0.0 | 0.0 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
| 0.0 | 0.2 | GO:0007602 | phototransduction(GO:0007602) |
| 0.0 | 0.1 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
| 0.0 | 0.1 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
| 0.0 | 0.2 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.0 | 0.2 | GO:0006744 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.0 | 0.1 | GO:0030252 | growth hormone secretion(GO:0030252) |
| 0.0 | 0.1 | GO:0023041 | neuronal signal transduction(GO:0023041) |
| 0.0 | 0.1 | GO:0045109 | intermediate filament organization(GO:0045109) |
| 0.0 | 0.0 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
| 0.0 | 0.2 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
| 0.0 | 0.0 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.0 | 0.3 | GO:0030488 | tRNA methylation(GO:0030488) |
| 0.0 | 0.3 | GO:0034063 | stress granule assembly(GO:0034063) |
| 0.0 | 0.1 | GO:0070542 | response to fatty acid(GO:0070542) |
| 0.0 | 0.1 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.0 | 0.3 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.0 | 0.1 | GO:0060134 | prepulse inhibition(GO:0060134) |
| 0.0 | 0.3 | GO:0060135 | maternal process involved in female pregnancy(GO:0060135) |
| 0.0 | 1.6 | GO:0045087 | innate immune response(GO:0045087) |
| 0.0 | 0.3 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
| 0.0 | 0.0 | GO:0043686 | co-translational protein modification(GO:0043686) |
| 0.0 | 0.0 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 11.3 | 34.0 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
| 5.2 | 31.4 | GO:0008091 | spectrin(GO:0008091) |
| 4.0 | 12.0 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
| 3.7 | 11.0 | GO:0034684 | integrin alphav-beta5 complex(GO:0034684) |
| 3.4 | 13.6 | GO:1990769 | proximal neuron projection(GO:1990769) |
| 3.1 | 3.1 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
| 3.1 | 9.2 | GO:0098830 | presynaptic endosome(GO:0098830) |
| 3.0 | 12.1 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
| 2.7 | 8.1 | GO:0044194 | cytolytic granule(GO:0044194) |
| 2.5 | 12.5 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
| 2.3 | 2.3 | GO:0071953 | elastic fiber(GO:0071953) |
| 2.2 | 42.2 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 2.2 | 6.6 | GO:0072534 | perineuronal net(GO:0072534) |
| 2.2 | 6.5 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
| 2.1 | 4.2 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
| 2.0 | 6.0 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
| 2.0 | 25.9 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 1.9 | 7.7 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
| 1.9 | 20.6 | GO:0032426 | stereocilium tip(GO:0032426) |
| 1.9 | 9.3 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
| 1.8 | 7.4 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
| 1.8 | 10.8 | GO:0045179 | apical cortex(GO:0045179) |
| 1.8 | 12.5 | GO:0070695 | FHF complex(GO:0070695) |
| 1.8 | 8.8 | GO:0044316 | cone cell pedicle(GO:0044316) |
| 1.8 | 8.8 | GO:0030314 | junctional membrane complex(GO:0030314) |
| 1.7 | 29.3 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 1.6 | 33.1 | GO:0032279 | asymmetric synapse(GO:0032279) |
| 1.5 | 7.6 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
| 1.5 | 4.5 | GO:0043512 | inhibin A complex(GO:0043512) |
| 1.5 | 23.7 | GO:0005614 | interstitial matrix(GO:0005614) |
| 1.5 | 22.0 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
| 1.5 | 18.9 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 1.4 | 7.2 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
| 1.4 | 15.7 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
| 1.4 | 22.2 | GO:0043196 | varicosity(GO:0043196) |
| 1.3 | 6.7 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
| 1.3 | 5.4 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
| 1.3 | 6.7 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
| 1.3 | 7.8 | GO:0035976 | AP1 complex(GO:0035976) |
| 1.3 | 6.5 | GO:1990037 | Lewy body core(GO:1990037) |
| 1.3 | 3.8 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
| 1.3 | 6.3 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 1.2 | 1.2 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
| 1.2 | 11.1 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
| 1.2 | 4.9 | GO:0031310 | integral component of vacuolar membrane(GO:0031166) intrinsic component of vacuolar membrane(GO:0031310) |
| 1.2 | 4.8 | GO:0005594 | collagen type IX trimer(GO:0005594) |
| 1.2 | 11.7 | GO:0045298 | tubulin complex(GO:0045298) |
| 1.2 | 78.9 | GO:0005581 | collagen trimer(GO:0005581) |
| 1.1 | 8.0 | GO:0030673 | axolemma(GO:0030673) |
| 1.1 | 2.2 | GO:0043083 | synaptic cleft(GO:0043083) |
| 1.0 | 6.3 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
| 1.0 | 5.2 | GO:0097444 | spine apparatus(GO:0097444) |
| 1.0 | 9.2 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 1.0 | 4.1 | GO:0032591 | dendritic spine membrane(GO:0032591) |
| 1.0 | 21.0 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
| 1.0 | 3.0 | GO:0005940 | septin ring(GO:0005940) |
| 1.0 | 9.9 | GO:0044327 | dendritic spine head(GO:0044327) |
| 1.0 | 10.8 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
| 1.0 | 2.0 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
| 1.0 | 1.9 | GO:0019815 | B cell receptor complex(GO:0019815) |
| 1.0 | 9.5 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.9 | 1.9 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
| 0.9 | 2.8 | GO:0005927 | muscle tendon junction(GO:0005927) cuticular plate(GO:0032437) |
| 0.9 | 7.3 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
| 0.9 | 4.5 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
| 0.9 | 9.7 | GO:0031091 | platelet alpha granule(GO:0031091) |
| 0.9 | 1.8 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
| 0.9 | 1.7 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
| 0.8 | 2.5 | GO:0044299 | C-fiber(GO:0044299) |
| 0.8 | 13.4 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.8 | 4.1 | GO:0036449 | microtubule minus-end(GO:0036449) |
| 0.8 | 2.5 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
| 0.8 | 4.9 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.8 | 6.5 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
| 0.8 | 12.0 | GO:0097449 | astrocyte projection(GO:0097449) |
| 0.8 | 11.9 | GO:0044292 | dendrite terminus(GO:0044292) |
| 0.8 | 7.0 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
| 0.8 | 2.3 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
| 0.8 | 3.8 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
| 0.8 | 3.0 | GO:0071556 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
| 0.7 | 52.1 | GO:0005604 | basement membrane(GO:0005604) |
| 0.7 | 2.9 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
| 0.7 | 23.7 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 0.7 | 6.9 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
| 0.7 | 2.1 | GO:0098842 | postsynaptic early endosome(GO:0098842) |
| 0.7 | 28.3 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
| 0.7 | 19.9 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
| 0.7 | 3.4 | GO:0097361 | CIA complex(GO:0097361) |
| 0.7 | 4.7 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
| 0.6 | 16.9 | GO:0033268 | node of Ranvier(GO:0033268) |
| 0.6 | 3.9 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
| 0.6 | 20.5 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
| 0.6 | 1.9 | GO:0034657 | GID complex(GO:0034657) |
| 0.6 | 0.6 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
| 0.6 | 12.9 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
| 0.6 | 22.8 | GO:0042734 | presynaptic membrane(GO:0042734) |
| 0.6 | 58.4 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
| 0.6 | 32.7 | GO:0034705 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
| 0.6 | 15.6 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
| 0.6 | 10.2 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
| 0.6 | 1.8 | GO:0002141 | stereocilia ankle link(GO:0002141) |
| 0.6 | 1.2 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
| 0.6 | 4.1 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
| 0.6 | 8.2 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
| 0.6 | 5.8 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 0.6 | 2.3 | GO:0033270 | paranode region of axon(GO:0033270) |
| 0.6 | 22.6 | GO:0009925 | basal plasma membrane(GO:0009925) |
| 0.6 | 0.6 | GO:0099524 | region of cytosol(GO:0099522) postsynaptic cytosol(GO:0099524) |
| 0.6 | 7.7 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
| 0.5 | 1.6 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
| 0.5 | 3.2 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
| 0.5 | 7.5 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 0.5 | 1.6 | GO:0045098 | type III intermediate filament(GO:0045098) |
| 0.5 | 25.5 | GO:0031594 | neuromuscular junction(GO:0031594) |
| 0.5 | 6.2 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.5 | 5.6 | GO:0032584 | growth cone membrane(GO:0032584) |
| 0.5 | 23.5 | GO:0030667 | secretory granule membrane(GO:0030667) |
| 0.5 | 1.5 | GO:0097386 | glial cell projection(GO:0097386) |
| 0.5 | 7.0 | GO:0031083 | BLOC-1 complex(GO:0031083) |
| 0.5 | 2.0 | GO:0045283 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
| 0.5 | 1.0 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
| 0.5 | 4.4 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.5 | 11.6 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.5 | 2.9 | GO:0005859 | muscle myosin complex(GO:0005859) |
| 0.5 | 1.8 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 0.5 | 1.8 | GO:0001651 | dense fibrillar component(GO:0001651) |
| 0.4 | 3.6 | GO:0097427 | microtubule bundle(GO:0097427) |
| 0.4 | 5.2 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
| 0.4 | 0.4 | GO:0019034 | viral replication complex(GO:0019034) |
| 0.4 | 3.4 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.4 | 11.7 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
| 0.4 | 1.6 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 0.4 | 2.0 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.4 | 2.0 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
| 0.4 | 6.4 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 0.4 | 4.3 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.4 | 1.9 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
| 0.4 | 14.3 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
| 0.4 | 6.1 | GO:0000145 | exocyst(GO:0000145) |
| 0.4 | 8.7 | GO:0032420 | stereocilium(GO:0032420) |
| 0.4 | 8.3 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.4 | 4.5 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
| 0.4 | 3.4 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
| 0.4 | 1.9 | GO:0070826 | paraferritin complex(GO:0070826) |
| 0.4 | 35.0 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
| 0.4 | 1.8 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
| 0.4 | 5.7 | GO:0005902 | microvillus(GO:0005902) |
| 0.4 | 2.9 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) clathrin-coated endocytic vesicle membrane(GO:0030669) |
| 0.4 | 2.5 | GO:0005638 | lamin filament(GO:0005638) |
| 0.3 | 2.1 | GO:0070852 | cell body fiber(GO:0070852) |
| 0.3 | 2.0 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
| 0.3 | 1.4 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
| 0.3 | 72.0 | GO:0097060 | synaptic membrane(GO:0097060) |
| 0.3 | 1.3 | GO:1990415 | Pex17p-Pex14p docking complex(GO:1990415) peroxisomal importomer complex(GO:1990429) |
| 0.3 | 3.0 | GO:0000439 | core TFIIH complex(GO:0000439) |
| 0.3 | 3.0 | GO:0061617 | MICOS complex(GO:0061617) |
| 0.3 | 0.7 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
| 0.3 | 2.3 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
| 0.3 | 5.7 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
| 0.3 | 1.9 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
| 0.3 | 2.2 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
| 0.3 | 0.3 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
| 0.3 | 0.6 | GO:1902636 | kinociliary basal body(GO:1902636) |
| 0.3 | 20.1 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
| 0.3 | 1.8 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.3 | 2.7 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
| 0.3 | 0.3 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
| 0.3 | 0.9 | GO:0033269 | internode region of axon(GO:0033269) |
| 0.3 | 1.5 | GO:1990745 | EARP complex(GO:1990745) |
| 0.3 | 0.9 | GO:0034457 | Mpp10 complex(GO:0034457) |
| 0.3 | 1.1 | GO:0042599 | lamellar body(GO:0042599) |
| 0.3 | 0.9 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
| 0.3 | 0.8 | GO:0033193 | Lsd1/2 complex(GO:0033193) |
| 0.3 | 1.1 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
| 0.3 | 3.4 | GO:0044754 | secondary lysosome(GO:0005767) autolysosome(GO:0044754) |
| 0.3 | 17.1 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
| 0.3 | 0.6 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
| 0.3 | 0.8 | GO:0097512 | cardiac myofibril(GO:0097512) |
| 0.3 | 6.0 | GO:0044295 | axonal growth cone(GO:0044295) |
| 0.3 | 1.6 | GO:0097443 | sorting endosome(GO:0097443) |
| 0.3 | 0.8 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
| 0.3 | 5.0 | GO:0030315 | T-tubule(GO:0030315) |
| 0.3 | 1.6 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 0.3 | 2.6 | GO:0016272 | prefoldin complex(GO:0016272) |
| 0.3 | 9.2 | GO:0045335 | phagocytic vesicle(GO:0045335) |
| 0.3 | 1.3 | GO:0030057 | desmosome(GO:0030057) |
| 0.3 | 3.5 | GO:0005811 | lipid particle(GO:0005811) |
| 0.2 | 1.5 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
| 0.2 | 0.7 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
| 0.2 | 8.4 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
| 0.2 | 0.7 | GO:0000235 | astral microtubule(GO:0000235) |
| 0.2 | 1.7 | GO:0097255 | R2TP complex(GO:0097255) |
| 0.2 | 5.7 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
| 0.2 | 0.2 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
| 0.2 | 0.2 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 0.2 | 1.2 | GO:0032590 | dendrite membrane(GO:0032590) |
| 0.2 | 1.1 | GO:0005683 | U7 snRNP(GO:0005683) |
| 0.2 | 5.1 | GO:0031305 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
| 0.2 | 0.9 | GO:0008537 | proteasome activator complex(GO:0008537) |
| 0.2 | 8.8 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
| 0.2 | 0.9 | GO:0097447 | dendritic tree(GO:0097447) |
| 0.2 | 1.5 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 0.2 | 0.6 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
| 0.2 | 23.6 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.2 | 2.8 | GO:0031941 | filamentous actin(GO:0031941) |
| 0.2 | 0.4 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
| 0.2 | 0.8 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
| 0.2 | 0.8 | GO:0031084 | BLOC-2 complex(GO:0031084) |
| 0.2 | 0.6 | GO:0042613 | MHC class II protein complex(GO:0042613) |
| 0.2 | 1.0 | GO:0070765 | gamma-secretase complex(GO:0070765) |
| 0.2 | 2.0 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
| 0.2 | 4.7 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
| 0.2 | 2.4 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
| 0.2 | 1.0 | GO:0060077 | inhibitory synapse(GO:0060077) |
| 0.2 | 1.0 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
| 0.2 | 1.2 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
| 0.2 | 0.2 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
| 0.2 | 3.8 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
| 0.2 | 0.8 | GO:0000322 | storage vacuole(GO:0000322) |
| 0.2 | 0.4 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
| 0.2 | 1.0 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
| 0.2 | 1.7 | GO:0002177 | manchette(GO:0002177) |
| 0.2 | 1.1 | GO:0016461 | unconventional myosin complex(GO:0016461) |
| 0.2 | 1.5 | GO:0033391 | chromatoid body(GO:0033391) |
| 0.2 | 0.9 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
| 0.2 | 2.6 | GO:0031932 | TORC2 complex(GO:0031932) |
| 0.2 | 0.7 | GO:0016342 | catenin complex(GO:0016342) |
| 0.2 | 0.5 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.2 | 10.5 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
| 0.2 | 2.7 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 0.2 | 2.7 | GO:0031672 | A band(GO:0031672) |
| 0.2 | 2.3 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
| 0.2 | 0.9 | GO:0070876 | SOSS complex(GO:0070876) |
| 0.2 | 4.3 | GO:0071565 | nBAF complex(GO:0071565) |
| 0.2 | 1.9 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
| 0.2 | 15.2 | GO:0030016 | myofibril(GO:0030016) |
| 0.2 | 9.9 | GO:0098862 | cluster of actin-based cell projections(GO:0098862) |
| 0.2 | 3.7 | GO:0031901 | early endosome membrane(GO:0031901) |
| 0.2 | 7.6 | GO:0005770 | late endosome(GO:0005770) |
| 0.2 | 3.4 | GO:0030914 | STAGA complex(GO:0030914) |
| 0.2 | 3.4 | GO:0055038 | recycling endosome membrane(GO:0055038) |
| 0.2 | 1.4 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 0.2 | 0.6 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
| 0.2 | 0.3 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
| 0.2 | 0.9 | GO:1990393 | 3M complex(GO:1990393) |
| 0.2 | 0.5 | GO:0014802 | terminal cisterna(GO:0014802) |
| 0.2 | 0.9 | GO:0000124 | SAGA complex(GO:0000124) |
| 0.2 | 1.5 | GO:0031527 | filopodium membrane(GO:0031527) |
| 0.2 | 2.7 | GO:0097228 | sperm principal piece(GO:0097228) |
| 0.2 | 2.3 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.2 | 1.2 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
| 0.1 | 0.4 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
| 0.1 | 0.4 | GO:0031258 | lamellipodium membrane(GO:0031258) |
| 0.1 | 1.2 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
| 0.1 | 5.3 | GO:0030686 | 90S preribosome(GO:0030686) |
| 0.1 | 0.1 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.1 | 23.0 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
| 0.1 | 2.5 | GO:0097440 | apical dendrite(GO:0097440) |
| 0.1 | 2.5 | GO:0016469 | proton-transporting two-sector ATPase complex(GO:0016469) |
| 0.1 | 0.6 | GO:0042581 | specific granule(GO:0042581) |
| 0.1 | 0.9 | GO:0042588 | zymogen granule(GO:0042588) |
| 0.1 | 4.5 | GO:0016328 | lateral plasma membrane(GO:0016328) |
| 0.1 | 1.0 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
| 0.1 | 0.8 | GO:0031143 | pseudopodium(GO:0031143) |
| 0.1 | 0.5 | GO:0071797 | LUBAC complex(GO:0071797) |
| 0.1 | 1.6 | GO:0043235 | receptor complex(GO:0043235) |
| 0.1 | 12.1 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
| 0.1 | 4.9 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
| 0.1 | 0.8 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
| 0.1 | 5.5 | GO:0016592 | mediator complex(GO:0016592) |
| 0.1 | 0.8 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 0.1 | 1.1 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
| 0.1 | 0.8 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
| 0.1 | 3.7 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.1 | 74.0 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
| 0.1 | 2.4 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.1 | 7.1 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
| 0.1 | 5.2 | GO:0005884 | actin filament(GO:0005884) |
| 0.1 | 1.9 | GO:0009897 | external side of plasma membrane(GO:0009897) |
| 0.1 | 0.2 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
| 0.1 | 0.8 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
| 0.1 | 0.2 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
| 0.1 | 13.7 | GO:0005802 | trans-Golgi network(GO:0005802) |
| 0.1 | 0.6 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
| 0.1 | 13.6 | GO:0001650 | fibrillar center(GO:0001650) |
| 0.1 | 10.3 | GO:0005769 | early endosome(GO:0005769) |
| 0.1 | 0.9 | GO:0061574 | ASAP complex(GO:0061574) |
| 0.1 | 1.2 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
| 0.1 | 0.4 | GO:0001652 | granular component(GO:0001652) |
| 0.1 | 0.3 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
| 0.1 | 0.2 | GO:0042583 | chromaffin granule(GO:0042583) |
| 0.1 | 0.8 | GO:0089701 | U2AF(GO:0089701) |
| 0.1 | 1.5 | GO:0042555 | MCM complex(GO:0042555) |
| 0.1 | 6.3 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
| 0.1 | 0.9 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
| 0.1 | 4.7 | GO:0072562 | blood microparticle(GO:0072562) |
| 0.1 | 0.1 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.1 | 3.0 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
| 0.1 | 0.6 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
| 0.1 | 1.2 | GO:0031985 | Golgi cisterna(GO:0031985) |
| 0.1 | 0.8 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
| 0.1 | 0.1 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
| 0.1 | 0.7 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.1 | 0.6 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
| 0.1 | 0.3 | GO:0031021 | interphase microtubule organizing center(GO:0031021) |
| 0.1 | 1.9 | GO:0070382 | exocytic vesicle(GO:0070382) |
| 0.1 | 0.3 | GO:0071141 | SMAD protein complex(GO:0071141) |
| 0.1 | 1.2 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
| 0.1 | 0.4 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
| 0.1 | 0.4 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
| 0.1 | 0.2 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
| 0.1 | 0.9 | GO:0016234 | inclusion body(GO:0016234) |
| 0.1 | 0.7 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
| 0.1 | 0.4 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
| 0.1 | 3.8 | GO:0043209 | myelin sheath(GO:0043209) |
| 0.1 | 0.2 | GO:0018444 | translation release factor complex(GO:0018444) |
| 0.1 | 4.7 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
| 0.0 | 0.2 | GO:0005827 | polar microtubule(GO:0005827) |
| 0.0 | 2.9 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 0.0 | 0.2 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
| 0.0 | 0.5 | GO:0060170 | ciliary membrane(GO:0060170) |
| 0.0 | 0.3 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
| 0.0 | 0.1 | GO:0070985 | TFIIK complex(GO:0070985) |
| 0.0 | 0.3 | GO:0034709 | methylosome(GO:0034709) |
| 0.0 | 0.3 | GO:0005687 | U4 snRNP(GO:0005687) |
| 0.0 | 0.1 | GO:0030677 | ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
| 0.0 | 0.3 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
| 0.0 | 0.3 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
| 0.0 | 0.3 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
| 0.0 | 0.2 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
| 0.0 | 0.1 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
| 0.0 | 0.4 | GO:0005839 | proteasome core complex(GO:0005839) |
| 0.0 | 0.2 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
| 0.0 | 0.2 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.0 | 0.3 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
| 0.0 | 0.2 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
| 0.0 | 0.1 | GO:0046930 | pore complex(GO:0046930) |
| 0.0 | 0.2 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
| 0.0 | 0.8 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
| 0.0 | 0.2 | GO:0000421 | autophagosome membrane(GO:0000421) |
| 0.0 | 4.0 | GO:0000139 | Golgi membrane(GO:0000139) |
| 0.0 | 0.1 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
| 0.0 | 0.1 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
| 0.0 | 0.1 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
| 0.0 | 0.5 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
| 0.0 | 2.4 | GO:0005768 | endosome(GO:0005768) |
| 0.0 | 0.2 | GO:0098793 | presynapse(GO:0098793) |
| 0.0 | 0.1 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 0.0 | 0.2 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
| 0.0 | 24.0 | GO:0016021 | integral component of membrane(GO:0016021) |
| 0.0 | 0.2 | GO:0035102 | PRC1 complex(GO:0035102) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 10.7 | 32.0 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
| 7.6 | 52.9 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
| 6.3 | 6.3 | GO:0048403 | neurotrophin binding(GO:0043121) brain-derived neurotrophic factor binding(GO:0048403) |
| 4.9 | 34.1 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
| 4.3 | 51.9 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
| 4.0 | 28.0 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
| 4.0 | 12.0 | GO:0046911 | hydroxyapatite binding(GO:0046848) metal chelating activity(GO:0046911) phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
| 3.9 | 19.7 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
| 3.4 | 16.9 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
| 3.1 | 12.4 | GO:0005008 | hepatocyte growth factor-activated receptor activity(GO:0005008) |
| 2.9 | 11.6 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
| 2.9 | 11.5 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 2.8 | 11.4 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
| 2.8 | 13.9 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
| 2.8 | 25.0 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
| 2.7 | 8.1 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
| 2.7 | 10.6 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
| 2.6 | 7.9 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
| 2.5 | 27.9 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 2.5 | 10.0 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
| 2.5 | 12.5 | GO:0097643 | amylin receptor activity(GO:0097643) |
| 2.4 | 12.2 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
| 2.4 | 7.3 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 2.4 | 7.3 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
| 2.4 | 9.7 | GO:0042834 | peptidoglycan binding(GO:0042834) |
| 2.4 | 26.4 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
| 2.4 | 9.4 | GO:0001639 | PLC activating G-protein coupled glutamate receptor activity(GO:0001639) G-protein coupled receptor activity involved in regulation of postsynaptic membrane potential(GO:0099530) |
| 2.2 | 6.7 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
| 2.2 | 6.7 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
| 2.2 | 8.8 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
| 2.1 | 21.3 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
| 2.1 | 12.6 | GO:0045340 | mercury ion binding(GO:0045340) |
| 2.1 | 8.2 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
| 2.0 | 5.9 | GO:0070890 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
| 1.9 | 9.6 | GO:0034235 | GPI anchor binding(GO:0034235) |
| 1.8 | 5.5 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
| 1.8 | 12.6 | GO:0099609 | microtubule lateral binding(GO:0099609) |
| 1.8 | 5.4 | GO:0019120 | hydrolase activity, acting on acid halide bonds(GO:0016824) hydrolase activity, acting on acid halide bonds, in C-halide compounds(GO:0019120) alkylhalidase activity(GO:0047651) |
| 1.7 | 5.2 | GO:0002153 | steroid receptor RNA activator RNA binding(GO:0002153) |
| 1.7 | 5.2 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
| 1.7 | 13.6 | GO:0032051 | clathrin light chain binding(GO:0032051) |
| 1.7 | 10.2 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
| 1.7 | 10.1 | GO:0050544 | arachidonic acid binding(GO:0050544) |
| 1.7 | 5.0 | GO:0031403 | lithium ion binding(GO:0031403) |
| 1.6 | 4.7 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
| 1.6 | 6.3 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
| 1.6 | 12.5 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 1.6 | 12.5 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
| 1.5 | 6.2 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
| 1.5 | 4.6 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
| 1.5 | 9.0 | GO:0019864 | immunoglobulin receptor activity(GO:0019763) IgG binding(GO:0019864) |
| 1.5 | 4.4 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
| 1.5 | 4.4 | GO:0004962 | endothelin receptor activity(GO:0004962) |
| 1.4 | 4.3 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
| 1.4 | 8.7 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
| 1.4 | 15.8 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 1.4 | 7.2 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
| 1.4 | 4.1 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
| 1.4 | 5.4 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
| 1.4 | 16.3 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
| 1.3 | 6.7 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
| 1.3 | 5.4 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
| 1.3 | 4.0 | GO:0008527 | taste receptor activity(GO:0008527) |
| 1.3 | 6.7 | GO:0043426 | MRF binding(GO:0043426) |
| 1.3 | 13.4 | GO:0031404 | chloride ion binding(GO:0031404) |
| 1.3 | 30.5 | GO:0030506 | ankyrin binding(GO:0030506) |
| 1.3 | 5.3 | GO:0004104 | cholinesterase activity(GO:0004104) choline binding(GO:0033265) |
| 1.3 | 7.7 | GO:0070699 | type II activin receptor binding(GO:0070699) |
| 1.3 | 14.0 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
| 1.3 | 6.3 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
| 1.3 | 3.8 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
| 1.3 | 15.1 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
| 1.3 | 6.3 | GO:0042610 | CD8 receptor binding(GO:0042610) |
| 1.2 | 6.0 | GO:0035174 | histone serine kinase activity(GO:0035174) |
| 1.2 | 3.6 | GO:0015928 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
| 1.2 | 3.6 | GO:0097677 | STAT family protein binding(GO:0097677) |
| 1.2 | 1.2 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
| 1.2 | 1.2 | GO:0031762 | alpha-1A adrenergic receptor binding(GO:0031691) alpha-1B adrenergic receptor binding(GO:0031692) follicle-stimulating hormone receptor binding(GO:0031762) |
| 1.2 | 3.5 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
| 1.2 | 14.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 1.2 | 4.6 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
| 1.1 | 4.5 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
| 1.1 | 14.6 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
| 1.1 | 3.4 | GO:0031798 | type 1 metabotropic glutamate receptor binding(GO:0031798) |
| 1.1 | 43.8 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
| 1.1 | 3.3 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
| 1.1 | 6.6 | GO:0033691 | sialic acid binding(GO:0033691) |
| 1.1 | 5.4 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
| 1.1 | 11.6 | GO:0019531 | secondary active sulfate transmembrane transporter activity(GO:0008271) oxalate transmembrane transporter activity(GO:0019531) |
| 1.1 | 41.2 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
| 1.1 | 3.2 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
| 1.0 | 14.7 | GO:0031005 | filamin binding(GO:0031005) |
| 1.0 | 5.2 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
| 1.0 | 3.1 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 1.0 | 3.1 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
| 1.0 | 4.1 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
| 1.0 | 6.0 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 1.0 | 6.0 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
| 1.0 | 15.7 | GO:0045499 | chemorepellent activity(GO:0045499) |
| 1.0 | 5.9 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
| 1.0 | 4.9 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
| 1.0 | 3.8 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) phospholipase A2 inhibitor activity(GO:0019834) |
| 1.0 | 4.8 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 0.9 | 3.8 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
| 0.9 | 3.8 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) |
| 0.9 | 4.7 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
| 0.9 | 17.7 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
| 0.9 | 5.6 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
| 0.9 | 5.5 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
| 0.9 | 7.3 | GO:0036122 | BMP binding(GO:0036122) |
| 0.9 | 21.6 | GO:0001968 | fibronectin binding(GO:0001968) |
| 0.9 | 0.9 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
| 0.9 | 14.4 | GO:0005044 | scavenger receptor activity(GO:0005044) |
| 0.9 | 3.6 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
| 0.9 | 20.6 | GO:0008009 | chemokine activity(GO:0008009) |
| 0.9 | 13.4 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
| 0.9 | 8.0 | GO:0008556 | sodium:potassium-exchanging ATPase activity(GO:0005391) potassium-transporting ATPase activity(GO:0008556) |
| 0.9 | 2.6 | GO:0009918 | sterol delta7 reductase activity(GO:0009918) 7-dehydrocholesterol reductase activity(GO:0047598) |
| 0.9 | 5.3 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
| 0.9 | 3.5 | GO:0003696 | satellite DNA binding(GO:0003696) |
| 0.9 | 7.9 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
| 0.9 | 2.6 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) enone reductase activity(GO:0035671) cholestenone 5-alpha-reductase activity(GO:0047751) |
| 0.9 | 9.6 | GO:0044213 | intronic transcription regulatory region DNA binding(GO:0044213) |
| 0.9 | 3.5 | GO:0030151 | molybdenum ion binding(GO:0030151) |
| 0.9 | 2.6 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
| 0.9 | 0.9 | GO:0008948 | oxaloacetate decarboxylase activity(GO:0008948) |
| 0.9 | 4.3 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
| 0.9 | 5.1 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
| 0.9 | 1.7 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
| 0.8 | 7.6 | GO:0008443 | phosphofructokinase activity(GO:0008443) |
| 0.8 | 3.3 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
| 0.8 | 1.7 | GO:0042289 | MHC class II protein binding(GO:0042289) |
| 0.8 | 2.5 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
| 0.8 | 0.8 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
| 0.8 | 9.8 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 0.8 | 11.4 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
| 0.8 | 4.9 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.8 | 17.0 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
| 0.8 | 5.6 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
| 0.8 | 12.0 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
| 0.8 | 2.4 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
| 0.8 | 23.1 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
| 0.8 | 2.4 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
| 0.8 | 3.2 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
| 0.8 | 10.3 | GO:0005522 | profilin binding(GO:0005522) |
| 0.8 | 6.3 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
| 0.8 | 3.1 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
| 0.8 | 7.8 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
| 0.8 | 13.1 | GO:0050811 | GABA receptor binding(GO:0050811) |
| 0.8 | 1.5 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 0.8 | 15.1 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
| 0.7 | 3.0 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.7 | 3.0 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 0.7 | 6.6 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
| 0.7 | 18.4 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
| 0.7 | 3.7 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
| 0.7 | 2.9 | GO:0031720 | haptoglobin binding(GO:0031720) |
| 0.7 | 6.6 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
| 0.7 | 1.4 | GO:0019863 | IgE binding(GO:0019863) |
| 0.7 | 24.3 | GO:0030552 | cAMP binding(GO:0030552) |
| 0.7 | 26.4 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
| 0.7 | 1.4 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
| 0.7 | 2.1 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
| 0.7 | 2.8 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
| 0.7 | 16.3 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 0.7 | 5.4 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
| 0.7 | 16.8 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.7 | 0.7 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
| 0.7 | 5.4 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
| 0.7 | 20.1 | GO:0030165 | PDZ domain binding(GO:0030165) |
| 0.7 | 6.7 | GO:0048406 | nerve growth factor binding(GO:0048406) |
| 0.7 | 2.6 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
| 0.7 | 14.5 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
| 0.6 | 3.2 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
| 0.6 | 4.5 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
| 0.6 | 2.6 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
| 0.6 | 3.2 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
| 0.6 | 4.5 | GO:0000150 | recombinase activity(GO:0000150) |
| 0.6 | 3.1 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
| 0.6 | 1.8 | GO:0016748 | succinyltransferase activity(GO:0016748) |
| 0.6 | 1.2 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
| 0.6 | 1.8 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
| 0.6 | 6.6 | GO:0043274 | phospholipase binding(GO:0043274) |
| 0.6 | 5.9 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
| 0.6 | 0.6 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
| 0.6 | 2.9 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
| 0.6 | 17.5 | GO:0005158 | insulin receptor binding(GO:0005158) |
| 0.6 | 6.4 | GO:0070412 | R-SMAD binding(GO:0070412) |
| 0.6 | 11.0 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
| 0.6 | 2.3 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
| 0.6 | 2.3 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
| 0.6 | 2.3 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
| 0.6 | 2.8 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
| 0.6 | 16.4 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 0.6 | 2.3 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
| 0.5 | 4.4 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.5 | 4.4 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
| 0.5 | 1.6 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) L-asparagine transmembrane transporter activity(GO:0015182) alanine transmembrane transporter activity(GO:0022858) |
| 0.5 | 19.7 | GO:0005516 | calmodulin binding(GO:0005516) |
| 0.5 | 1.6 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
| 0.5 | 4.9 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
| 0.5 | 3.8 | GO:0050897 | cobalt ion binding(GO:0050897) |
| 0.5 | 3.2 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
| 0.5 | 1.6 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
| 0.5 | 4.8 | GO:1990459 | transferrin receptor binding(GO:1990459) |
| 0.5 | 5.3 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
| 0.5 | 7.4 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
| 0.5 | 1.6 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
| 0.5 | 2.6 | GO:0043237 | laminin-1 binding(GO:0043237) |
| 0.5 | 2.6 | GO:0004954 | icosanoid receptor activity(GO:0004953) prostanoid receptor activity(GO:0004954) prostaglandin receptor activity(GO:0004955) |
| 0.5 | 14.9 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
| 0.5 | 2.0 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
| 0.5 | 5.6 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
| 0.5 | 7.1 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.5 | 1.0 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
| 0.5 | 0.5 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
| 0.5 | 6.4 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
| 0.5 | 0.5 | GO:0048185 | activin binding(GO:0048185) |
| 0.5 | 7.3 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
| 0.5 | 2.4 | GO:0055100 | adiponectin binding(GO:0055100) |
| 0.5 | 1.4 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
| 0.5 | 10.6 | GO:0042805 | actinin binding(GO:0042805) |
| 0.5 | 1.4 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
| 0.5 | 1.0 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
| 0.5 | 2.4 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
| 0.5 | 1.9 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
| 0.5 | 1.9 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
| 0.5 | 3.3 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
| 0.5 | 2.8 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
| 0.5 | 18.8 | GO:0046875 | ephrin receptor binding(GO:0046875) |
| 0.5 | 0.5 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
| 0.5 | 9.8 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 0.5 | 1.4 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
| 0.4 | 2.7 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
| 0.4 | 1.3 | GO:0003977 | UDP-N-acetylglucosamine diphosphorylase activity(GO:0003977) |
| 0.4 | 1.8 | GO:0070012 | oligopeptidase activity(GO:0070012) |
| 0.4 | 41.1 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
| 0.4 | 3.5 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
| 0.4 | 1.7 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
| 0.4 | 3.5 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
| 0.4 | 17.2 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
| 0.4 | 1.7 | GO:0035877 | death effector domain binding(GO:0035877) |
| 0.4 | 2.6 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
| 0.4 | 1.7 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
| 0.4 | 0.8 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
| 0.4 | 7.9 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
| 0.4 | 5.8 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
| 0.4 | 1.2 | GO:0070492 | oligosaccharide binding(GO:0070492) |
| 0.4 | 2.9 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
| 0.4 | 1.6 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
| 0.4 | 11.9 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 0.4 | 25.2 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
| 0.4 | 2.0 | GO:0004385 | guanylate kinase activity(GO:0004385) |
| 0.4 | 1.2 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
| 0.4 | 1.6 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
| 0.4 | 2.4 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
| 0.4 | 4.0 | GO:0001618 | virus receptor activity(GO:0001618) |
| 0.4 | 0.8 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
| 0.4 | 0.8 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
| 0.4 | 6.7 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
| 0.4 | 0.8 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
| 0.4 | 1.6 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
| 0.4 | 3.1 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.4 | 1.9 | GO:0042731 | PH domain binding(GO:0042731) |
| 0.4 | 0.8 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
| 0.4 | 1.9 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
| 0.4 | 0.8 | GO:0030519 | snoRNP binding(GO:0030519) |
| 0.4 | 1.1 | GO:0003680 | AT DNA binding(GO:0003680) |
| 0.4 | 4.2 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
| 0.4 | 1.5 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
| 0.4 | 1.1 | GO:0071209 | U7 snRNA binding(GO:0071209) |
| 0.4 | 2.3 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
| 0.4 | 1.1 | GO:0043758 | acetate-CoA ligase (ADP-forming) activity(GO:0043758) |
| 0.4 | 7.3 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 0.4 | 2.9 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
| 0.4 | 1.4 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
| 0.4 | 2.5 | GO:0071253 | connexin binding(GO:0071253) |
| 0.4 | 1.4 | GO:0033142 | progesterone receptor binding(GO:0033142) |
| 0.4 | 5.0 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
| 0.4 | 1.1 | GO:0002060 | purine nucleobase binding(GO:0002060) |
| 0.4 | 2.8 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.3 | 3.1 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
| 0.3 | 1.7 | GO:0008761 | UDP-N-acetylglucosamine 2-epimerase activity(GO:0008761) |
| 0.3 | 1.7 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 0.3 | 6.8 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
| 0.3 | 3.7 | GO:0005402 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
| 0.3 | 1.0 | GO:0015929 | hexosaminidase activity(GO:0015929) |
| 0.3 | 2.7 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
| 0.3 | 1.7 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
| 0.3 | 15.5 | GO:0015485 | cholesterol binding(GO:0015485) |
| 0.3 | 1.0 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
| 0.3 | 2.6 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
| 0.3 | 11.1 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
| 0.3 | 11.4 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
| 0.3 | 1.9 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
| 0.3 | 3.2 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.3 | 1.3 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
| 0.3 | 1.0 | GO:0015232 | heme transporter activity(GO:0015232) |
| 0.3 | 1.9 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.3 | 2.2 | GO:0001515 | opioid peptide activity(GO:0001515) |
| 0.3 | 0.9 | GO:0008502 | melatonin receptor activity(GO:0008502) |
| 0.3 | 0.9 | GO:0008176 | tRNA (guanine-N7-)-methyltransferase activity(GO:0008176) |
| 0.3 | 1.6 | GO:0016151 | nickel cation binding(GO:0016151) |
| 0.3 | 1.2 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
| 0.3 | 5.5 | GO:0030275 | LRR domain binding(GO:0030275) |
| 0.3 | 0.9 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 0.3 | 1.2 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
| 0.3 | 2.4 | GO:0000182 | rDNA binding(GO:0000182) |
| 0.3 | 1.8 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 0.3 | 1.2 | GO:0039706 | co-receptor binding(GO:0039706) |
| 0.3 | 3.8 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
| 0.3 | 1.5 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
| 0.3 | 3.2 | GO:0004622 | lysophospholipase activity(GO:0004622) |
| 0.3 | 8.9 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
| 0.3 | 8.5 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.3 | 7.1 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
| 0.3 | 1.1 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
| 0.3 | 1.7 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
| 0.3 | 1.4 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
| 0.3 | 14.0 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
| 0.3 | 1.4 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
| 0.3 | 2.2 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
| 0.3 | 5.2 | GO:0050840 | extracellular matrix binding(GO:0050840) |
| 0.3 | 1.1 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
| 0.3 | 1.9 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
| 0.3 | 2.2 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
| 0.3 | 1.1 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
| 0.3 | 1.6 | GO:0030331 | estrogen receptor binding(GO:0030331) |
| 0.3 | 2.1 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
| 0.3 | 14.6 | GO:0019213 | deacetylase activity(GO:0019213) |
| 0.3 | 0.8 | GO:0072541 | peroxynitrite reductase activity(GO:0072541) |
| 0.3 | 1.8 | GO:0042287 | MHC protein binding(GO:0042287) |
| 0.3 | 0.8 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
| 0.3 | 2.3 | GO:0030955 | potassium ion binding(GO:0030955) |
| 0.3 | 0.5 | GO:0030350 | iron-responsive element binding(GO:0030350) |
| 0.3 | 5.6 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
| 0.3 | 1.3 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
| 0.2 | 2.0 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 0.2 | 2.2 | GO:0051434 | BH3 domain binding(GO:0051434) |
| 0.2 | 1.7 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.2 | 0.7 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
| 0.2 | 0.7 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
| 0.2 | 1.2 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
| 0.2 | 1.0 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
| 0.2 | 3.6 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.2 | 0.7 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
| 0.2 | 0.2 | GO:0004340 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) |
| 0.2 | 0.5 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
| 0.2 | 0.2 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
| 0.2 | 2.8 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
| 0.2 | 0.5 | GO:0036004 | GAF domain binding(GO:0036004) |
| 0.2 | 2.1 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
| 0.2 | 0.7 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
| 0.2 | 0.7 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
| 0.2 | 1.1 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
| 0.2 | 0.7 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
| 0.2 | 0.9 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
| 0.2 | 0.9 | GO:0097110 | scaffold protein binding(GO:0097110) |
| 0.2 | 0.9 | GO:0004064 | arylesterase activity(GO:0004064) |
| 0.2 | 0.9 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
| 0.2 | 8.4 | GO:0016247 | channel regulator activity(GO:0016247) |
| 0.2 | 1.1 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
| 0.2 | 0.9 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
| 0.2 | 0.9 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
| 0.2 | 2.4 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
| 0.2 | 0.6 | GO:0019779 | Atg12 activating enzyme activity(GO:0019778) Atg8 activating enzyme activity(GO:0019779) |
| 0.2 | 0.6 | GO:0008061 | chitin binding(GO:0008061) |
| 0.2 | 2.1 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.2 | 0.6 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
| 0.2 | 0.8 | GO:0043532 | angiostatin binding(GO:0043532) |
| 0.2 | 0.8 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
| 0.2 | 0.6 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
| 0.2 | 17.2 | GO:0008201 | heparin binding(GO:0008201) |
| 0.2 | 0.2 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
| 0.2 | 0.6 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
| 0.2 | 0.6 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
| 0.2 | 0.4 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
| 0.2 | 1.9 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
| 0.2 | 0.4 | GO:0031628 | opioid receptor binding(GO:0031628) |
| 0.2 | 1.9 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
| 0.2 | 2.3 | GO:0000339 | RNA cap binding(GO:0000339) |
| 0.2 | 0.8 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
| 0.2 | 3.4 | GO:0008143 | poly(A) binding(GO:0008143) |
| 0.2 | 3.4 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
| 0.2 | 0.8 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
| 0.2 | 3.2 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.2 | 7.3 | GO:0008536 | Ran GTPase binding(GO:0008536) |
| 0.2 | 5.2 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
| 0.2 | 1.1 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
| 0.2 | 1.7 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 0.2 | 1.1 | GO:0050692 | DBD domain binding(GO:0050692) |
| 0.2 | 1.3 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
| 0.2 | 1.3 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
| 0.2 | 3.7 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
| 0.2 | 0.5 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 0.2 | 0.9 | GO:0043199 | sulfate binding(GO:0043199) |
| 0.2 | 3.7 | GO:0035254 | glutamate receptor binding(GO:0035254) |
| 0.2 | 2.3 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.2 | 0.7 | GO:0005093 | Rab GDP-dissociation inhibitor activity(GO:0005093) |
| 0.2 | 1.5 | GO:0035591 | signaling adaptor activity(GO:0035591) |
| 0.2 | 1.2 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 0.2 | 1.0 | GO:0005042 | netrin receptor activity(GO:0005042) |
| 0.2 | 0.7 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
| 0.2 | 0.5 | GO:0031996 | thioesterase binding(GO:0031996) |
| 0.2 | 10.0 | GO:0032947 | protein complex scaffold(GO:0032947) |
| 0.2 | 0.5 | GO:0001888 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) |
| 0.2 | 0.3 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
| 0.2 | 3.8 | GO:0032183 | SUMO binding(GO:0032183) |
| 0.2 | 1.4 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
| 0.2 | 0.8 | GO:0070404 | NADH binding(GO:0070404) |
| 0.2 | 3.4 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
| 0.2 | 1.1 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.2 | 1.2 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
| 0.2 | 0.8 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
| 0.2 | 1.8 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
| 0.2 | 0.5 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
| 0.1 | 0.6 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
| 0.1 | 4.7 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 0.1 | 4.9 | GO:0030507 | spectrin binding(GO:0030507) |
| 0.1 | 1.1 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
| 0.1 | 1.4 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.1 | 3.8 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
| 0.1 | 1.6 | GO:0015643 | toxic substance binding(GO:0015643) |
| 0.1 | 8.6 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 0.1 | 0.7 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
| 0.1 | 1.8 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
| 0.1 | 0.1 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
| 0.1 | 7.3 | GO:0051117 | ATPase binding(GO:0051117) |
| 0.1 | 0.7 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
| 0.1 | 2.0 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
| 0.1 | 1.2 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
| 0.1 | 2.4 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
| 0.1 | 2.6 | GO:0005262 | calcium channel activity(GO:0005262) |
| 0.1 | 0.4 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
| 0.1 | 0.5 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
| 0.1 | 0.6 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
| 0.1 | 20.8 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.1 | 1.3 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 0.1 | 4.1 | GO:0016876 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
| 0.1 | 0.5 | GO:0036468 | aromatic-L-amino-acid decarboxylase activity(GO:0004058) L-dopa decarboxylase activity(GO:0036468) |
| 0.1 | 2.9 | GO:0051059 | NF-kappaB binding(GO:0051059) |
| 0.1 | 0.6 | GO:0005112 | Notch binding(GO:0005112) |
| 0.1 | 0.6 | GO:0031543 | peptidyl-proline dioxygenase activity(GO:0031543) |
| 0.1 | 8.0 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
| 0.1 | 0.4 | GO:1990955 | G-rich single-stranded DNA binding(GO:1990955) |
| 0.1 | 0.5 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
| 0.1 | 0.5 | GO:0016018 | cyclosporin A binding(GO:0016018) |
| 0.1 | 30.3 | GO:0005096 | GTPase activator activity(GO:0005096) |
| 0.1 | 2.3 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
| 0.1 | 0.3 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
| 0.1 | 1.1 | GO:0015266 | protein channel activity(GO:0015266) |
| 0.1 | 0.5 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
| 0.1 | 0.3 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
| 0.1 | 0.7 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.1 | 0.3 | GO:0018738 | S-formylglutathione hydrolase activity(GO:0018738) |
| 0.1 | 0.7 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
| 0.1 | 0.4 | GO:0035514 | DNA demethylase activity(GO:0035514) |
| 0.1 | 0.6 | GO:0000298 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) |
| 0.1 | 26.7 | GO:0003924 | GTPase activity(GO:0003924) |
| 0.1 | 0.3 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
| 0.1 | 0.3 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
| 0.1 | 2.6 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
| 0.1 | 1.2 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
| 0.1 | 0.6 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
| 0.1 | 0.7 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
| 0.1 | 0.6 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
| 0.1 | 0.4 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
| 0.1 | 0.8 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
| 0.1 | 0.1 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
| 0.1 | 1.9 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
| 0.1 | 0.3 | GO:0036361 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
| 0.1 | 0.4 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 0.1 | 1.0 | GO:0043422 | protein kinase B binding(GO:0043422) |
| 0.1 | 0.2 | GO:0031702 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
| 0.1 | 0.9 | GO:0000049 | tRNA binding(GO:0000049) |
| 0.1 | 0.6 | GO:0008312 | 7S RNA binding(GO:0008312) |
| 0.1 | 0.4 | GO:0016411 | acylglycerol O-acyltransferase activity(GO:0016411) |
| 0.1 | 5.7 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
| 0.1 | 2.3 | GO:0042562 | hormone binding(GO:0042562) |
| 0.1 | 0.9 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.1 | 0.8 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
| 0.1 | 0.4 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
| 0.1 | 0.7 | GO:0005521 | lamin binding(GO:0005521) |
| 0.1 | 0.2 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
| 0.1 | 0.9 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 0.1 | 0.5 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
| 0.1 | 0.4 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
| 0.1 | 5.9 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.1 | 1.4 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
| 0.1 | 0.4 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 0.1 | 5.6 | GO:0044325 | ion channel binding(GO:0044325) |
| 0.1 | 0.3 | GO:1990715 | mRNA CDS binding(GO:1990715) |
| 0.1 | 0.6 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
| 0.1 | 4.7 | GO:0005178 | integrin binding(GO:0005178) |
| 0.1 | 2.3 | GO:0004497 | monooxygenase activity(GO:0004497) |
| 0.1 | 0.8 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
| 0.1 | 0.4 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
| 0.1 | 0.3 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 0.1 | 3.1 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
| 0.1 | 0.2 | GO:0017166 | vinculin binding(GO:0017166) |
| 0.1 | 0.5 | GO:0004043 | L-aminoadipate-semialdehyde dehydrogenase activity(GO:0004043) |
| 0.1 | 0.4 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
| 0.1 | 0.7 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
| 0.1 | 0.1 | GO:0031685 | adenosine receptor binding(GO:0031685) |
| 0.1 | 0.1 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
| 0.1 | 1.5 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 0.1 | 1.5 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
| 0.1 | 0.2 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
| 0.1 | 0.1 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
| 0.1 | 0.5 | GO:0070628 | proteasome binding(GO:0070628) |
| 0.1 | 0.3 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
| 0.1 | 0.9 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
| 0.1 | 0.4 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
| 0.1 | 0.3 | GO:0050733 | RS domain binding(GO:0050733) |
| 0.1 | 2.4 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.1 | 0.1 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
| 0.1 | 0.6 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
| 0.1 | 0.4 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
| 0.1 | 0.2 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
| 0.1 | 2.8 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
| 0.1 | 0.4 | GO:0016428 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
| 0.1 | 0.3 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
| 0.1 | 0.1 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 0.1 | 0.1 | GO:0038132 | neuregulin binding(GO:0038132) |
| 0.1 | 0.4 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.1 | 0.2 | GO:2001069 | glycogen binding(GO:2001069) |
| 0.1 | 0.4 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
| 0.1 | 0.6 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 0.1 | 0.4 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 0.1 | 0.9 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.1 | 1.6 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
| 0.1 | 0.2 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
| 0.1 | 0.1 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
| 0.1 | 0.2 | GO:0003998 | acylphosphatase activity(GO:0003998) |
| 0.1 | 0.3 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
| 0.1 | 1.4 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
| 0.1 | 4.6 | GO:0005198 | structural molecule activity(GO:0005198) |
| 0.1 | 0.2 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 0.1 | 0.4 | GO:0030332 | cyclin binding(GO:0030332) |
| 0.1 | 0.1 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
| 0.1 | 1.9 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.1 | 0.1 | GO:0008534 | oxidized purine nucleobase lesion DNA N-glycosylase activity(GO:0008534) |
| 0.1 | 0.6 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
| 0.0 | 0.3 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
| 0.0 | 0.1 | GO:0034711 | inhibin binding(GO:0034711) |
| 0.0 | 0.0 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
| 0.0 | 0.3 | GO:1990446 | U1 snRNP binding(GO:1990446) |
| 0.0 | 0.1 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
| 0.0 | 0.5 | GO:0001222 | transcription corepressor binding(GO:0001222) |
| 0.0 | 0.2 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 0.0 | 0.4 | GO:0008066 | glutamate receptor activity(GO:0008066) |
| 0.0 | 0.2 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
| 0.0 | 0.1 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
| 0.0 | 0.9 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
| 0.0 | 1.3 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
| 0.0 | 0.0 | GO:0009041 | uridylate kinase activity(GO:0009041) |
| 0.0 | 0.6 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
| 0.0 | 0.3 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
| 0.0 | 0.3 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
| 0.0 | 0.4 | GO:0031386 | protein tag(GO:0031386) |
| 0.0 | 0.2 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
| 0.0 | 0.6 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
| 0.0 | 0.3 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
| 0.0 | 0.5 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
| 0.0 | 0.1 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
| 0.0 | 0.2 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 0.0 | 0.1 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
| 0.0 | 0.3 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
| 0.0 | 0.1 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
| 0.0 | 0.8 | GO:0008083 | growth factor activity(GO:0008083) |
| 0.0 | 0.7 | GO:0015297 | antiporter activity(GO:0015297) |
| 0.0 | 0.7 | GO:0005179 | hormone activity(GO:0005179) |
| 0.0 | 1.4 | GO:0008013 | beta-catenin binding(GO:0008013) |
| 0.0 | 0.1 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
| 0.0 | 0.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
| 0.0 | 0.1 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
| 0.0 | 0.1 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
| 0.0 | 1.2 | GO:0051082 | unfolded protein binding(GO:0051082) |
| 0.0 | 0.1 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
| 0.0 | 0.0 | GO:0001160 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
| 0.0 | 0.1 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
| 0.0 | 0.2 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 0.0 | 0.0 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
| 0.0 | 0.2 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
| 0.0 | 0.1 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
| 0.0 | 0.0 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.4 | 24.4 | PID_LPA4_PATHWAY | LPA4-mediated signaling events |
| 1.2 | 26.5 | PID_PDGFRA_PATHWAY | PDGFR-alpha signaling pathway |
| 1.1 | 1.1 | PID_ALK2_PATHWAY | ALK2 signaling events |
| 1.0 | 17.5 | PID_MAPK_TRK_PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 1.0 | 16.2 | PID_INTEGRIN5_PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 1.0 | 27.9 | PID_INTEGRIN_A9B1_PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.9 | 13.6 | PID_ERBB_NETWORK_PATHWAY | ErbB receptor signaling network |
| 0.9 | 56.3 | PID_ERBB1_INTERNALIZATION_PATHWAY | Internalization of ErbB1 |
| 0.8 | 28.0 | PID_ENDOTHELIN_PATHWAY | Endothelins |
| 0.8 | 58.1 | PID_RHOA_REG_PATHWAY | Regulation of RhoA activity |
| 0.8 | 30.4 | PID_REELIN_PATHWAY | Reelin signaling pathway |
| 0.8 | 7.5 | SA_MMP_CYTOKINE_CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 0.7 | 2.2 | ST_IL_13_PATHWAY | Interleukin 13 (IL-13) Pathway |
| 0.7 | 39.6 | PID_TRKR_PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
| 0.7 | 0.7 | ST_INTERFERON_GAMMA_PATHWAY | Interferon gamma pathway. |
| 0.7 | 4.7 | PID_VEGFR1_2_PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
| 0.6 | 13.1 | PID_EPO_PATHWAY | EPO signaling pathway |
| 0.6 | 4.3 | PID_NECTIN_PATHWAY | Nectin adhesion pathway |
| 0.6 | 6.6 | PID_INTEGRIN2_PATHWAY | Beta2 integrin cell surface interactions |
| 0.6 | 108.9 | NABA_SECRETED_FACTORS | Genes encoding secreted soluble factors |
| 0.5 | 4.1 | PID_IL2_STAT5_PATHWAY | IL2 signaling events mediated by STAT5 |
| 0.5 | 9.8 | SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
| 0.5 | 10.8 | ST_ERK1_ERK2_MAPK_PATHWAY | ERK1/ERK2 MAPK Pathway |
| 0.5 | 8.6 | SIG_IL4RECEPTOR_IN_B_LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
| 0.5 | 19.3 | PID_INSULIN_PATHWAY | Insulin Pathway |
| 0.5 | 4.2 | PID_RHODOPSIN_PATHWAY | Visual signal transduction: Rods |
| 0.5 | 1.9 | PID_S1P_S1P2_PATHWAY | S1P2 pathway |
| 0.5 | 9.7 | PID_INTEGRIN_A4B1_PATHWAY | Alpha4 beta1 integrin signaling events |
| 0.5 | 37.1 | PID_PDGFRB_PATHWAY | PDGFR-beta signaling pathway |
| 0.5 | 8.7 | PID_CIRCADIAN_PATHWAY | Circadian rhythm pathway |
| 0.4 | 10.1 | ST_WNT_CA2_CYCLIC_GMP_PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
| 0.4 | 6.0 | PID_PI3K_PLC_TRK_PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 0.4 | 17.1 | PID_ATF2_PATHWAY | ATF-2 transcription factor network |
| 0.4 | 14.1 | NABA_PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.4 | 2.8 | PID_ER_NONGENOMIC_PATHWAY | Plasma membrane estrogen receptor signaling |
| 0.4 | 11.9 | PID_FGF_PATHWAY | FGF signaling pathway |
| 0.4 | 4.6 | ST_GA12_PATHWAY | G alpha 12 Pathway |
| 0.4 | 4.9 | PID_IL8_CXCR1_PATHWAY | IL8- and CXCR1-mediated signaling events |
| 0.4 | 45.2 | NABA_ECM_AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.4 | 10.8 | PID_ARF_3PATHWAY | Arf1 pathway |
| 0.4 | 2.6 | PID_RAC1_PATHWAY | RAC1 signaling pathway |
| 0.4 | 2.9 | PID_KIT_PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.3 | 0.3 | PID_TCR_JNK_PATHWAY | JNK signaling in the CD4+ TCR pathway |
| 0.3 | 6.0 | PID_IL12_STAT4_PATHWAY | IL12 signaling mediated by STAT4 |
| 0.3 | 6.2 | PID_LIS1_PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
| 0.3 | 16.7 | PID_AP1_PATHWAY | AP-1 transcription factor network |
| 0.3 | 1.9 | PID_WNT_SIGNALING_PATHWAY | Wnt signaling network |
| 0.3 | 4.7 | PID_ALPHA_SYNUCLEIN_PATHWAY | Alpha-synuclein signaling |
| 0.3 | 6.8 | SIG_CHEMOTAXIS | Genes related to chemotaxis |
| 0.3 | 3.6 | PID_PRL_SIGNALING_EVENTS_PATHWAY | Signaling events mediated by PRL |
| 0.3 | 5.2 | PID_IL4_2PATHWAY | IL4-mediated signaling events |
| 0.3 | 2.8 | SA_PROGRAMMED_CELL_DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.2 | 1.2 | PID_TRAIL_PATHWAY | TRAIL signaling pathway |
| 0.2 | 27.5 | NABA_ECM_GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.2 | 4.5 | PID_HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.2 | 2.7 | ST_G_ALPHA_S_PATHWAY | G alpha s Pathway |
| 0.2 | 1.1 | PID_VEGF_VEGFR_PATHWAY | VEGF and VEGFR signaling network |
| 0.2 | 2.5 | PID_PI3KCI_PATHWAY | Class I PI3K signaling events |
| 0.2 | 0.4 | PID_IL23_PATHWAY | IL23-mediated signaling events |
| 0.2 | 1.8 | ST_G_ALPHA_I_PATHWAY | G alpha i Pathway |
| 0.2 | 2.9 | PID_EPHA_FWDPATHWAY | EPHA forward signaling |
| 0.2 | 7.5 | NABA_BASEMENT_MEMBRANES | Genes encoding structural components of basement membranes |
| 0.2 | 10.1 | PID_LKB1_PATHWAY | LKB1 signaling events |
| 0.2 | 1.8 | PID_INTEGRIN3_PATHWAY | Beta3 integrin cell surface interactions |
| 0.2 | 7.7 | PID_AR_TF_PATHWAY | Regulation of Androgen receptor activity |
| 0.2 | 1.4 | PID_SHP2_PATHWAY | SHP2 signaling |
| 0.2 | 7.6 | PID_BMP_PATHWAY | BMP receptor signaling |
| 0.2 | 1.0 | PID_AMB2_NEUTROPHILS_PATHWAY | amb2 Integrin signaling |
| 0.2 | 0.7 | PID_UPA_UPAR_PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
| 0.2 | 0.8 | ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
| 0.2 | 0.3 | ST_T_CELL_SIGNAL_TRANSDUCTION | T Cell Signal Transduction |
| 0.2 | 2.5 | PID_P38_ALPHA_BETA_PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.2 | 3.6 | PID_RB_1PATHWAY | Regulation of retinoblastoma protein |
| 0.2 | 5.6 | PID_RXR_VDR_PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.2 | 1.9 | PID_RET_PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.2 | 9.5 | PID_HIF1_TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.1 | 0.6 | ST_PHOSPHOINOSITIDE_3_KINASE_PATHWAY | PI3K Pathway |
| 0.1 | 0.8 | PID_GMCSF_PATHWAY | GMCSF-mediated signaling events |
| 0.1 | 3.1 | PID_CDC42_REG_PATHWAY | Regulation of CDC42 activity |
| 0.1 | 7.2 | PID_ERA_GENOMIC_PATHWAY | Validated nuclear estrogen receptor alpha network |
| 0.1 | 13.6 | NABA_ECM_REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.1 | 1.5 | PID_WNT_CANONICAL_PATHWAY | Canonical Wnt signaling pathway |
| 0.1 | 3.5 | PID_MTOR_4PATHWAY | mTOR signaling pathway |
| 0.1 | 0.6 | PID_PTP1B_PATHWAY | Signaling events mediated by PTP1B |
| 0.1 | 0.6 | PID_IL1_PATHWAY | IL1-mediated signaling events |
| 0.1 | 2.1 | PID_MYC_REPRESS_PATHWAY | Validated targets of C-MYC transcriptional repression |
| 0.1 | 0.6 | PID_IL2_PI3K_PATHWAY | IL2 signaling events mediated by PI3K |
| 0.1 | 0.4 | PID_FOXO_PATHWAY | FoxO family signaling |
| 0.0 | 2.7 | PID_P53_REGULATION_PATHWAY | p53 pathway |
| 0.0 | 0.3 | PID_A6B1_A6B4_INTEGRIN_PATHWAY | a6b1 and a6b4 Integrin signaling |
| 0.0 | 0.5 | ST_TUMOR_NECROSIS_FACTOR_PATHWAY | Tumor Necrosis Factor Pathway. |
| 0.0 | 0.2 | PID_RETINOIC_ACID_PATHWAY | Retinoic acid receptors-mediated signaling |
| 0.0 | 0.2 | PID_NFKAPPAB_ATYPICAL_PATHWAY | Atypical NF-kappaB pathway |
| 0.0 | 0.1 | PID_SYNDECAN_4_PATHWAY | Syndecan-4-mediated signaling events |
| 0.0 | 0.4 | SIG_CD40PATHWAYMAP | Genes related to CD40 signaling |
| 0.0 | 0.1 | PID_NFKAPPAB_CANONICAL_PATHWAY | Canonical NF-kappaB pathway |
| 0.0 | 0.4 | PID_MYC_PATHWAY | C-MYC pathway |
| 0.0 | 0.4 | PID_TGFBR_PATHWAY | TGF-beta receptor signaling |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 5.1 | 30.8 | REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
| 3.4 | 33.8 | REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
| 2.6 | 15.4 | REACTOME_COMMON_PATHWAY | Genes involved in Common Pathway |
| 2.5 | 7.6 | REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
| 2.3 | 29.6 | REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
| 2.2 | 43.1 | REACTOME_RETROGRADE_NEUROTROPHIN_SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
| 2.0 | 46.2 | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | Genes involved in PKA-mediated phosphorylation of CREB |
| 1.7 | 46.4 | REACTOME_DCC_MEDIATED_ATTRACTIVE_SIGNALING | Genes involved in DCC mediated attractive signaling |
| 1.6 | 11.0 | REACTOME_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS | Genes involved in Tandem pore domain potassium channels |
| 1.6 | 12.5 | REACTOME_TRANSPORT_OF_ORGANIC_ANIONS | Genes involved in Transport of organic anions |
| 1.4 | 17.9 | REACTOME_SIGNAL_REGULATORY_PROTEIN_SIRP_FAMILY_INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 1.4 | 2.7 | REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING | Genes involved in SHC1 events in EGFR signaling |
| 1.3 | 41.9 | REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
| 1.3 | 20.9 | REACTOME_GABA_A_RECEPTOR_ACTIVATION | Genes involved in GABA A receptor activation |
| 1.3 | 40.4 | REACTOME_BASIGIN_INTERACTIONS | Genes involved in Basigin interactions |
| 1.3 | 9.1 | REACTOME_ENDOGENOUS_STEROLS | Genes involved in Endogenous sterols |
| 1.1 | 11.3 | REACTOME_CA_DEPENDENT_EVENTS | Genes involved in Ca-dependent events |
| 1.1 | 7.9 | REACTOME_CD28_DEPENDENT_VAV1_PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
| 1.1 | 4.5 | REACTOME_GLYCOPROTEIN_HORMONES | Genes involved in Glycoprotein hormones |
| 1.0 | 9.9 | REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
| 1.0 | 32.8 | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.9 | 22.0 | REACTOME_RAS_ACTIVATION_UOPN_CA2_INFUX_THROUGH_NMDA_RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
| 0.9 | 21.5 | REACTOME_ERK_MAPK_TARGETS | Genes involved in ERK/MAPK targets |
| 0.9 | 21.2 | REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
| 0.9 | 15.7 | REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
| 0.9 | 10.4 | REACTOME_NEPHRIN_INTERACTIONS | Genes involved in Nephrin interactions |
| 0.9 | 6.0 | REACTOME_GAMMA_CARBOXYLATION_TRANSPORT_AND_AMINO_TERMINAL_CLEAVAGE_OF_PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
| 0.8 | 13.2 | REACTOME_ACTIVATION_OF_THE_AP1_FAMILY_OF_TRANSCRIPTION_FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
| 0.8 | 0.8 | REACTOME_POST_NMDA_RECEPTOR_ACTIVATION_EVENTS | Genes involved in Post NMDA receptor activation events |
| 0.8 | 13.7 | REACTOME_IL_RECEPTOR_SHC_SIGNALING | Genes involved in Interleukin receptor SHC signaling |
| 0.8 | 10.3 | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 0.8 | 8.4 | REACTOME_SHC_MEDIATED_SIGNALLING | Genes involved in SHC-mediated signalling |
| 0.7 | 9.7 | REACTOME_REGULATION_OF_RHEB_GTPASE_ACTIVITY_BY_AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
| 0.7 | 7.4 | REACTOME_ACTIVATION_OF_RAC | Genes involved in Activation of Rac |
| 0.7 | 2.9 | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | Genes involved in Cell surface interactions at the vascular wall |
| 0.7 | 10.2 | REACTOME_CHYLOMICRON_MEDIATED_LIPID_TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 0.7 | 17.5 | REACTOME_CHOLESTEROL_BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.7 | 24.6 | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.7 | 18.2 | REACTOME_RAP1_SIGNALLING | Genes involved in Rap1 signalling |
| 0.7 | 9.8 | REACTOME_TIE2_SIGNALING | Genes involved in Tie2 Signaling |
| 0.7 | 4.0 | REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
| 0.7 | 0.7 | REACTOME_NFKB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL | Genes involved in NF-kB is activated and signals survival |
| 0.7 | 4.0 | REACTOME_INHIBITION_OF_INSULIN_SECRETION_BY_ADRENALINE_NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
| 0.7 | 16.4 | REACTOME_LATENT_INFECTION_OF_HOMO_SAPIENS_WITH_MYCOBACTERIUM_TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
| 0.7 | 2.6 | REACTOME_ANDROGEN_BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
| 0.6 | 10.1 | REACTOME_BOTULINUM_NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
| 0.6 | 3.1 | REACTOME_ACETYLCHOLINE_NEUROTRANSMITTER_RELEASE_CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
| 0.6 | 9.9 | REACTOME_SYNTHESIS_OF_SUBSTRATES_IN_N_GLYCAN_BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
| 0.6 | 4.3 | REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.6 | 3.6 | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 0.6 | 12.4 | REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 0.5 | 6.0 | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.5 | 9.2 | REACTOME_PURINE_SALVAGE | Genes involved in Purine salvage |
| 0.5 | 5.3 | REACTOME_REGULATION_OF_WATER_BALANCE_BY_RENAL_AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
| 0.5 | 10.8 | REACTOME_RNA_POL_III_CHAIN_ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
| 0.5 | 5.6 | REACTOME_IL_3_5_AND_GM_CSF_SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
| 0.5 | 4.1 | REACTOME_FGFR4_LIGAND_BINDING_AND_ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
| 0.5 | 11.5 | REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.5 | 16.3 | REACTOME_SYNTHESIS_OF_PA | Genes involved in Synthesis of PA |
| 0.5 | 10.8 | REACTOME_DARPP_32_EVENTS | Genes involved in DARPP-32 events |
| 0.5 | 4.9 | REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
| 0.5 | 2.4 | REACTOME_BILE_SALT_AND_ORGANIC_ANION_SLC_TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
| 0.5 | 11.4 | REACTOME_SULFUR_AMINO_ACID_METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 0.5 | 5.6 | REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.5 | 5.1 | REACTOME_GABA_SYNTHESIS_RELEASE_REUPTAKE_AND_DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
| 0.5 | 12.1 | REACTOME_AMINO_ACID_SYNTHESIS_AND_INTERCONVERSION_TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
| 0.5 | 9.0 | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 0.4 | 6.6 | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_ACTIVITY_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.4 | 15.4 | REACTOME_HS_GAG_BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.4 | 4.2 | REACTOME_KERATAN_SULFATE_DEGRADATION | Genes involved in Keratan sulfate degradation |
| 0.4 | 2.5 | REACTOME_LIPID_DIGESTION_MOBILIZATION_AND_TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
| 0.4 | 2.1 | REACTOME_ACYL_CHAIN_REMODELLING_OF_PS | Genes involved in Acyl chain remodelling of PS |
| 0.4 | 4.5 | REACTOME_FACILITATIVE_NA_INDEPENDENT_GLUCOSE_TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.4 | 15.3 | REACTOME_INWARDLY_RECTIFYING_K_CHANNELS | Genes involved in Inwardly rectifying K+ channels |
| 0.4 | 3.7 | REACTOME_CRMPS_IN_SEMA3A_SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.4 | 0.4 | REACTOME_MRNA_DECAY_BY_3_TO_5_EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
| 0.3 | 7.9 | REACTOME_SYNTHESIS_OF_PC | Genes involved in Synthesis of PC |
| 0.3 | 2.6 | REACTOME_THE_ACTIVATION_OF_ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
| 0.3 | 5.3 | REACTOME_SIGNALING_BY_NODAL | Genes involved in Signaling by NODAL |
| 0.3 | 1.8 | REACTOME_GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
| 0.3 | 0.9 | REACTOME_SYNTHESIS_OF_PE | Genes involved in Synthesis of PE |
| 0.3 | 5.4 | REACTOME_FORMATION_OF_ATP_BY_CHEMIOSMOTIC_COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
| 0.3 | 8.2 | REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.3 | 3.5 | REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 0.3 | 5.4 | REACTOME_N_GLYCAN_ANTENNAE_ELONGATION | Genes involved in N-Glycan antennae elongation |
| 0.3 | 3.9 | REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.3 | 3.9 | REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
| 0.3 | 3.0 | REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
| 0.3 | 11.7 | REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.3 | 0.8 | REACTOME_HORMONE_LIGAND_BINDING_RECEPTORS | Genes involved in Hormone ligand-binding receptors |
| 0.3 | 5.9 | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| 0.3 | 0.5 | REACTOME_FORMATION_OF_TRANSCRIPTION_COUPLED_NER_TC_NER_REPAIR_COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
| 0.3 | 4.2 | REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.3 | 1.8 | REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS | Genes involved in G alpha (z) signalling events |
| 0.2 | 8.3 | REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.2 | 0.7 | REACTOME_CS_DS_DEGRADATION | Genes involved in CS/DS degradation |
| 0.2 | 9.2 | REACTOME_GLYCOLYSIS | Genes involved in Glycolysis |
| 0.2 | 6.0 | REACTOME_METAL_ION_SLC_TRANSPORTERS | Genes involved in Metal ion SLC transporters |
| 0.2 | 2.4 | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 0.2 | 1.2 | REACTOME_ACYL_CHAIN_REMODELLING_OF_PG | Genes involved in Acyl chain remodelling of PG |
| 0.2 | 0.9 | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | Genes involved in NRAGE signals death through JNK |
| 0.2 | 7.4 | REACTOME_SMOOTH_MUSCLE_CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 0.2 | 37.6 | REACTOME_SIGNALING_BY_RHO_GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.2 | 2.3 | REACTOME_PURINE_METABOLISM | Genes involved in Purine metabolism |
| 0.2 | 2.4 | REACTOME_REGULATION_OF_IFNA_SIGNALING | Genes involved in Regulation of IFNA signaling |
| 0.2 | 12.1 | REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.2 | 0.8 | REACTOME_DSCAM_INTERACTIONS | Genes involved in DSCAM interactions |
| 0.2 | 3.1 | REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
| 0.2 | 1.2 | REACTOME_ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
| 0.2 | 4.9 | REACTOME_SIGNALING_BY_BMP | Genes involved in Signaling by BMP |
| 0.2 | 5.5 | REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
| 0.2 | 1.0 | REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
| 0.2 | 4.2 | REACTOME_BRANCHED_CHAIN_AMINO_ACID_CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.2 | 8.8 | REACTOME_G_ALPHA_S_SIGNALLING_EVENTS | Genes involved in G alpha (s) signalling events |
| 0.2 | 6.4 | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | Genes involved in Adherens junctions interactions |
| 0.2 | 12.6 | REACTOME_RESPIRATORY_ELECTRON_TRANSPORT | Genes involved in Respiratory electron transport |
| 0.2 | 12.4 | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.2 | 1.3 | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
| 0.2 | 0.5 | REACTOME_SIGNALLING_TO_P38_VIA_RIT_AND_RIN | Genes involved in Signalling to p38 via RIT and RIN |
| 0.2 | 1.6 | REACTOME_ADVANCED_GLYCOSYLATION_ENDPRODUCT_RECEPTOR_SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 0.2 | 0.9 | REACTOME_ABACAVIR_TRANSPORT_AND_METABOLISM | Genes involved in Abacavir transport and metabolism |
| 0.2 | 4.7 | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.2 | 8.4 | REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.2 | 6.4 | REACTOME_SIGNALING_BY_ERBB2 | Genes involved in Signaling by ERBB2 |
| 0.2 | 1.3 | REACTOME_ROLE_OF_DCC_IN_REGULATING_APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.2 | 8.1 | REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_ | Genes involved in Response to elevated platelet cytosolic Ca2+ |
| 0.2 | 6.4 | REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.2 | 1.9 | REACTOME_CALNEXIN_CALRETICULIN_CYCLE | Genes involved in Calnexin/calreticulin cycle |
| 0.2 | 0.5 | REACTOME_ARMS_MEDIATED_ACTIVATION | Genes involved in ARMS-mediated activation |
| 0.2 | 8.5 | REACTOME_FORMATION_OF_THE_TERNARY_COMPLEX_AND_SUBSEQUENTLY_THE_43S_COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
| 0.2 | 8.5 | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | Genes involved in G alpha (i) signalling events |
| 0.2 | 1.9 | REACTOME_PREFOLDIN_MEDIATED_TRANSFER_OF_SUBSTRATE_TO_CCT_TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
| 0.2 | 1.8 | REACTOME_COPI_MEDIATED_TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.2 | 0.8 | REACTOME_ORGANIC_CATION_ANION_ZWITTERION_TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 0.1 | 1.0 | REACTOME_HORMONE_SENSITIVE_LIPASE_HSL_MEDIATED_TRIACYLGLYCEROL_HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.1 | 1.7 | REACTOME_MTORC1_MEDIATED_SIGNALLING | Genes involved in mTORC1-mediated signalling |
| 0.1 | 0.7 | REACTOME_PROTEIN_FOLDING | Genes involved in Protein folding |
| 0.1 | 0.8 | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
| 0.1 | 3.5 | REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.1 | 0.4 | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | Genes involved in Notch-HLH transcription pathway |
| 0.1 | 0.5 | REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
| 0.1 | 1.3 | REACTOME_EXTRINSIC_PATHWAY_FOR_APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
| 0.1 | 0.1 | REACTOME_DESTABILIZATION_OF_MRNA_BY_BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
| 0.1 | 2.0 | REACTOME_TRNA_AMINOACYLATION | Genes involved in tRNA Aminoacylation |
| 0.1 | 2.3 | REACTOME_RNA_POL_I_TRANSCRIPTION_TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
| 0.1 | 2.5 | REACTOME_SYNTHESIS_AND_INTERCONVERSION_OF_NUCLEOTIDE_DI_AND_TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 0.1 | 0.2 | REACTOME_THE_ROLE_OF_NEF_IN_HIV1_REPLICATION_AND_DISEASE_PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
| 0.1 | 0.3 | REACTOME_TRANSPORT_OF_RIBONUCLEOPROTEINS_INTO_THE_HOST_NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
| 0.1 | 2.5 | REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
| 0.1 | 0.9 | REACTOME_TRAF6_MEDIATED_INDUCTION_OF_TAK1_COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
| 0.1 | 10.2 | REACTOME_TRANSLATION | Genes involved in Translation |
| 0.1 | 1.3 | REACTOME_NEF_MEDIATED_DOWNREGULATION_OF_MHC_CLASS_I_COMPLEX_CELL_SURFACE_EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 0.1 | 5.0 | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.1 | 3.5 | REACTOME_GLUCOSE_TRANSPORT | Genes involved in Glucose transport |
| 0.1 | 0.8 | REACTOME_PTM_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
| 0.1 | 0.9 | REACTOME_NRIF_SIGNALS_CELL_DEATH_FROM_THE_NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
| 0.1 | 0.5 | REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
| 0.1 | 2.4 | REACTOME_CLASS_A1_RHODOPSIN_LIKE_RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
| 0.1 | 0.9 | REACTOME_LYSOSOME_VESICLE_BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
| 0.1 | 3.4 | REACTOME_REGULATION_OF_APOPTOSIS | Genes involved in Regulation of Apoptosis |
| 0.1 | 0.8 | REACTOME_DESTABILIZATION_OF_MRNA_BY_KSRP | Genes involved in Destabilization of mRNA by KSRP |
| 0.1 | 0.1 | REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT | Genes involved in Initial triggering of complement |
| 0.1 | 0.7 | REACTOME_SLBP_DEPENDENT_PROCESSING_OF_REPLICATION_DEPENDENT_HISTONE_PRE_MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
| 0.1 | 0.6 | REACTOME_METABOLISM_OF_POLYAMINES | Genes involved in Metabolism of polyamines |
| 0.1 | 0.2 | REACTOME_IL_6_SIGNALING | Genes involved in Interleukin-6 signaling |
| 0.1 | 0.5 | REACTOME_GAP_JUNCTION_DEGRADATION | Genes involved in Gap junction degradation |
| 0.1 | 0.2 | REACTOME_DOPAMINE_NEUROTRANSMITTER_RELEASE_CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
| 0.1 | 1.4 | REACTOME_SYNTHESIS_OF_VERY_LONG_CHAIN_FATTY_ACYL_COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
| 0.0 | 0.9 | REACTOME_NONSENSE_MEDIATED_DECAY_ENHANCED_BY_THE_EXON_JUNCTION_COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
| 0.0 | 1.5 | REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
| 0.0 | 0.2 | REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
| 0.0 | 0.3 | REACTOME_IRON_UPTAKE_AND_TRANSPORT | Genes involved in Iron uptake and transport |
| 0.0 | 0.3 | REACTOME_SIGNALLING_TO_RAS | Genes involved in Signalling to RAS |
| 0.0 | 0.3 | REACTOME_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
| 0.0 | 1.7 | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | Genes involved in MHC class II antigen presentation |
| 0.0 | 0.5 | REACTOME_GLUTATHIONE_CONJUGATION | Genes involved in Glutathione conjugation |
| 0.0 | 0.9 | REACTOME_NCAM1_INTERACTIONS | Genes involved in NCAM1 interactions |
| 0.0 | 0.2 | REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
| 0.0 | 0.3 | REACTOME_HOMOLOGOUS_RECOMBINATION_REPAIR_OF_REPLICATION_INDEPENDENT_DOUBLE_STRAND_BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
| 0.0 | 0.0 | REACTOME_ION_CHANNEL_TRANSPORT | Genes involved in Ion channel transport |
|
|
|